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Healthcare providers are faced with many challenges when trying to meet the complex needs of those with age 
related diseases, such as dementia. In residential aged care facilities (RACFs), up to 90% of those with dementia 
exhibit responsive behaviours (RB) and these are associated with increases in mortality, morbidity and 
decreased quality-of-life for residents. The term ‘responsive behaviours’ refers to words and actions displayed in 
response to personal, social or physical environments and are an expression of meaning, needs or concerns. 
There is a need for more focus in policy, practice and research to improve the management of and reduce the 
negative impacts of RB on residents and care staff within RACFs. Affective RB symptoms in particular have 
been found to be the most burdensome. In time constrained workplaces, care staff require guidance towards 
resources that can facilitate better evidence based practice (EBP).  This research adopts the Outcome-Focused 
Knowledge Translation Framework (OFKTF) in its investigation of knowledge translation (KT) with the aim of 
identifying best ‘sources of evidence’ to inform practices which are useful to care staff to support residents with 
affective RB. Specifically, the series of studies undertaken investigates the value of different approaches to 
synthesis and identifying best ‘sources of evidence’ to guide knowledge translation.  Study 1 utilises panoramic 
meta-analysis (a statistical method pooling effect estimates over systematic reviews and meta-analyses, similar 
to a systematic review of systematic reviews and meta-analyses) to synthesise the available literature on non-
pharmacological interventions for affective RB. However this method was unable to generate definitive 
recommendations for the non-pharmacological intervention of affective symptoms. This is due to heterogeneity 
and sampling issues within the included RCTs and insufficient number of RCTs to generate power within the 
calculations. Despite this, the review highlights overall positive outcomes from the use of non-pharmacological 
interventions for affective symptoms. It is also useful to generate three tentative recommendations regarding the 
best available interventions for practice: music therapy for anxiety, staff development for depression and person-
centred care for aggression. Despite some value, the study concludes that EB management of RBs in RACFs 
would also benefit from alternative sources of evidence including expert opinion and an assessment of the 





To address this, Study 2 identifies available clinical guidelines using a systematic search and assesses 
their quality using the Intervention Centre for Allied Health Evidence (iCAHE) guideline quality checklist. Two 
of seven identified CPGs reach a high level of quality. Despite being ranked second, The Behaviour 
Management: A Guide to good Practice (DBMAS) guide is judged to be the clearest, most complete and easiest 
to navigate CPG. Quality assessment is found to be insufficient in isolation to identify best sources of evidence 
but has promise when used in conjunction with other methods such as clinical expertise.  
Following on from this, Study 3 sought to establish expert opinion regarding best available guidelines 
for management of RB. This is achieved through surveying a panel of experts on their use and recommendation 
of different CPGs. Results from this study highlight the Behaviour Management: A Guide to good Practice 
(DBMAS) as a high quality guideline with expert preference. Expert preference for guidelines was the same for 
both overall management of RBs and specifically for the management of affective symptoms. The survey 
method is able to generate clearer recommendations for RB interventions by comparing quality assessment with 
expert opinion to reveal the Behaviour Management: A Guide to good Practice (DBMAS) as a high-quality CPG 
with expert recommendation. However, the results should be interpreted with caution, due to the small and 
potentially biased sample for the study. The additional value of expert opinion (study 3) to identify best sources 
of evidence is less conclusive due to study bias. However, overall, the value of mixed methods approaches when 
identifying ‘sources of evidence’ for KT, should be promoted, especially where the quality of evidence is low. 
The studies undertaken highlight that the different methods (research synthesis (study 1) and analysis of quality 
and usability of guidelines (study 2)) are useful to assist in identifying best ‘sources of evidence’ for non-
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Chapter 1 - Introduction 
“NOW IS THE TIME TO MAKE IT HAPPEN WHERE IT MATTERS, BY TURNING SCIENTIFIC KNOWLEDGE INTO 
EFFECTIVE ACTION FOR PEOPLE’S HEALTH”  
DIRECTOR-GENERAL OF THE WORLD HEALTH ORGANIZATION, DR  J.W.LEE 
Background  
Medical discoveries and improvements in public health services have  extended the human lifespan over the past 
decades and led to an increase in ageing populations, or what has come to be known as the “Grey Tsunami” [1]. 
In 2016, there were approximately 3.7 million people in Australia over the age of 65 [2]. This is estimated to 
reach 8.1 million by 2056 [3]. Hand in hand with this increased longevity is the increase in diseases with age as 
a primary risk factor, such as dementia. The prevalence of dementia is estimated to be doubling every 20 years 
and it is predicted that by 2050 there will be close to 1 million people with dementia in Australia and 135 
million worldwide [4].  With this, a greater focus on the disease in policy, practice and research is not only 
necessary but is a critical health priority [1].  
 
Those  who develop dementia account for more than half the residents in supported residential accommodation 
[5]. Within these facilities, up to 90% of residents living with dementia experience Behavioural and 
Psychological Symptoms of Dementia (BPSD) and have associated increases in mortality, morbidity and 
decreased quality-of-life [6], [7] [8]. BPSD refers to the diversity of non-cognitive responses and behaviours in 
populations with dementia and includes symptoms such as agitation, depression, anxiety, apathy, delusions, 
hallucinations and sleep or appetite changes [8]. Although BPSD is the common term within the literature, it is 
now preferable to refer to these as ‘responsive behaviours’ (RB). This term was coined by, and preferred by [9], 
those with dementia to reflect that their words and actions are a response to their personal, social or physical 
environments and are an expression of meaning, needs or concerns [10]. For clarity, this term has been adopted 
within this research. These responsive behaviours can affect up to 90% of the those with a dementia diagnosis, 





As dementia progresses the presentation of RB changes and it is useful to cluster symptoms to create sub-
syndromes that reflect distinctive incidence, trajectories over time, biological correlates, and psychosocial 
determinants [11]. There are often co-morbidities and correlates in the causes and intervention of RB. In this 
research, clustering was necessary to limit the scope of research to manageable proportions and to focus the 
research on the most burdensome symptom cluster.  The Neuropsychiatric Inventory (NPI) is the most 
commonly used and recommended assessment of RB within research and clinical realms and has been the main 
vehicle in the study of symptom taxonomy [12], [13]. While no consensus in regard to symptom grouping has 
yet been reached, the NPI derived symptom grouping set forth by Aalten and colleagues [14] is the most 
commonly used taxonomy within the literature. It  divides symptoms into three classes; psychotic symptoms, 
affective/mood symptoms and behavioural symptoms [14]. Canevelli [15] systematically reviewed the literature 
on factor analysis of the NPI and found a 75% consensus for three clusters found within the 10-item NPI and a 
57.1% consensus of four clusters within the 12-item version. The most frequent clusters were ‘psychosis 
(delusions, hallucinations and sleep and night time behaviour)’, ‘behavioural (elation/euphoria, disinhibition, 
appetite and aberrant motor behaviour)’, and mood/affective (depression/dysphoria, agitation/aggression, 
irritability and anxiety). These groups have been adopted in the current research given their high consensus 
within the literature.   
 
The debate over cluster definition continues as there are symptoms (apathy, night-time behaviour and appetite 
behaviour) that are inconsistently placed throughout the literature [16]. Apathy is of concern in relation to 
affective/mood grouping. The distinction of apathy and depression is recognised by some [17], [18] but not by 
others [14]. It is, however, most commonly associated with the affective cluster when not classed as its own 
category and should be considered here for generalizability and ease of consensus.  Given the evidence available 
on both most agreed upon clusters and most common placing of debatable symptoms (apathy, appetite, sleep) 
the following symptom taxonomy has been adopted in this research as the best available synthesis of current 
views.  The affective cluster may be the most burdensome within the healthcare system as it encompasses the 
three most prevalent non-cognitive symptoms within dementia; apathy, depression and anxiety [11]. Given the 
scope of the RB literature, this Masters thesis adopted an affective symptom focus in its exploration of Sources 





Table 1. Most consistent clustering of neuropsychiatric symptoms within the literature [17] 
Psychotic/Psychosis Behavioural/hyperactive Mood/affective 
Delusions Euphoria/elation Depression/dysphoria 
Hallucinations Disinhibition Agitation/aggression 
Night-time behaviour Eating/appetite behaviour Irritability 
 Aberrant motor behaviour Anxiety 
  Apathy 
 
The problem of responding appropriately to responsive behaviours 
 
The presence of RB in persons with dementia is associated with earlier placement  within  care  facilities,  
difficultly  performing  activities  of  daily  living  (ADL) [19],  decreased  cognitive  ability,  emotional  
regularity,  functionality  and  insight [20].   Clinically,  it  reduces  the  likelihood  of  help-seeking  behaviour,  
quality  of  life  and  survival  rate  after  facility  admission  [21], [22].  
 
RACF staff are significantly affected by RB presentation.  Increased  frequency  of  RB  is  correlated  with  
reports  of  emotional  strain  and  less  positive  work  environments [23],  declined  physical  health  and  
work  attendance  and  increased  burnout [24]. In the absence of support for the application of non-
pharmacological interventions, including time allocation with residents and to attend training,  care staff often 
rely on chemical or physical restraints to manage RB [11], [25]–[27]. Estimates  suggest  that  84%  of  people  
with  dementia  living  in  RACFs  are  prescribed  medication  to  relieve  the  symptoms  of  RB [28]  and  are  
often  the  first  choice  treatment  strategies  for  nursing  staff  due  to  ease  of  administration  and  rapid  
effect.  This  is  despite  the  fact  that  systematic  reviews  have  found  little  evidence  of  the  effectiveness  
of  pharmacological  treatments  and  increased  problems  with  side  effects  such  as  stroke,  cognitive  
decline  and  fatality [29], [30].  
  
The level of care needed by residents in Australian aged care homes is increasingly complex. However,  the  
ratio  of  registered  nurses  to  care staff  is  reducing  with  more  and  more  homes  relying  on  having  a  




64%  of  care  facility  staff  have been found to be care staff  hired  for  cost-saving  reasons  [32]. Although  
this  is  improving,  this  population  is  still  of  particular  interest  and  are  a  particular  challenge  as  they  
often have additional barriers  to  attending  training, such as having multiple jobs or not being reimbursed,  
despite  being  the  most  closely  involved  in  the  day-to-day  care  of  residents  when  compared  to  
registered  nurses [33]. Care staff can be under trained in identifying the  aetiology  of  problem  behaviours, 
accessing  quality resources or in selection of resources to  assist  decision-making  and  behaviour  
management [34].  In  order  to  improve  the  care  given  by  care staff,  various  factors  need  to  be  
addressed [33].  These  include  support  of decision  making  processes  through  ongoing  support  and  the  
provision  of  easy -to-use  research  tools such as clinical practice guidelines (CPGs)  [35].   
 
CPG are defined as statements  that  include  recommendations for EBP  care  that  are usually  informed  by  a  
systematic  reviews and  an  assessment of  alternative  care  options [36]. CPGs offer one option for assistance 
and supplementation of formal training for care staff in the evidence-based alleviation of RB. The aim of CPGs 
in RACFs is to “enhance research translation by synthesising recent evidence for health and aged care 
professionals” [37]. A number of guidelines for interventions for dementia have been developed yet there is 
little guidance available, or have expired, to help care staff select the most appropriate guideline [38]. The 
delivery of quality care requires that care staff are supported and educated in their decision making, yet it is 
unclear which guidelines facilitate the use of evidence in practice [11]. Care-staff can feel that taking time out 
from their work schedule to investigate current EBP is unethical as it takes time and focus from resident care 
[13]. Further, end users of CPGs have the expectation that resources will be of high quality and fit for purpose, 
yet guidelines have been found to be of varying quality[38]. Easily accessible high quality research evidence 
that is usable and understandable is needed. Research into the aetiology, treatment and care of RB is quite well 
established with promising results. Yet, it is practically inaccessible because care staff do not have the time, 
resources or skills to navigate large quantities of data to make evidence-based decisions.  Further, design of 
guidelines needs to consider application within practical realms by care staff and must be assessed for quality to 
ensure they are promoting EBP.  For  example,  a  perceived  lack  of  knowledge  of  academic  processes  and  
forms  of  communication  have  limited  the  applicability  of  research  and CPGs must  be  translated  into  a  
user-friendly  language [39].  Research reports and articles tend to be written for academic audiences, but they 
are unlikely to be usable within non-academic populations.  Given this, the quality, selection of and usability of 






As the proportion of Australians with a dementia diagnosis grows and the impact on those affected, their 
caregivers, healthcare systems, and the economy increases, the need to effectively translate research evidence 
into policy and practice becomes paramount. The primary objective of Knowledge Translation (KT) is to 
increase the tendency for care staff to utilise evidence-based research findings to inform health-care practices 
[39]. KT frameworks have the potential to guide research syntheses to generate clear recommendations for care 
and increase EBP. Knowledge Translation (KT) addresses the challenge of bridging the “know-do” gap [40]. It 
works from the premise that research has little value or legitimacy without being put into practice, being tested 
for clinical efficacy, and without being regularly evaluated. Translation of dementia related research has been 
determined to be a ‘Global Health Priority’ by the WHO [1] and a ‘National Priority’ by Australian 
governmental bodies [41]. Research evidence should underpin all action and reach those who can apply it to 
inform decisions [1]. In healthcare, KT has been defined as “the synthesis, exchange, and application of 
knowledge by relevant stakeholders to accelerate the benefits of global and local innovation in strengthening 
health systems and improving people’s health” [42]. The following terms are overlapping and interrelated in the 
literature regarding knowledge translation; diffusion, dissemination, brokering, implementation, knowledge 
transfer, knowledge exchange, knowledge mobility, linkage and exchange, research into practice, research 
utilisation, evidence-based decision-making, knowledge uptake, research uptake, and research transfer [42]–
[46]. In fact, there are over 90 terms for these processes [47]. Knowledge Translation (KT) is a process that 
encompasses the key concepts within many of these terms with the goal of ‘Evidence-Based Practice (EBP)’ 
and has been used within this document to describe the efforts leading to the uptake of evidence in practice. It is 
the most frequently accepted within the literature and has notions of practical utility with a focus beyond simple 
understanding through to action (e.g., decision-making [48]).  
 
The core of KT is the need to translate results successfully, yet often attempts are unsuccessful. One explanation 
for this is the absence of theory-driven development of tools, intervention and assessment. Developing KT 
strategies based on theory allows for identification of focus (i.e., population specific tools), explanations (i.e., 
what works for whom and why) and generation of theoretically transferable knowledge [49]. KT strategies must 





Promoting Action on Research Implementation in Health Services (PARIHS) is a conceptual framework [50] 
which proposes that healthcare decision making relies upon the uptake of current best practice information, 
patient preferences and insight into patient responses [40]. The PARIHS framework allows for mixed-methods 
approaches, modelling research utilisation and assessing designs.  Furthermore, the WHO report on KT 
frameworks identified the PARIHS as one of the few successful frameworks to work within clinical or 
organisational settings (rather than national or policy levels)[40]. The PARIHS follows a rationale that KT 
involves linking of research to action as a decision-making process or problem to be solved through problem 
identification, identification of research, and application of knowledge. Further the PAHRIS incorporates a 
“Successful Implementation (SI) Tool” which presents the notions that Successful Implementation (SI) is a 
function of Evidence (E), Context (C), and Facilitation (F), with Evidence being first line in approach.  
SI = function of E, C, F. 
In response to the PARIHS framework, Doran and Sidani [51] set out to design an Outcome-Focused 
Knowledge Translation Framework (OFKTF)  under the rationale that reconceptualising how care-staff “access 
information and designing appropriate decision support systems to facilitate timely designed focused on four 
key components adapted from the PARIHS framework and has advantage in directing research and practice 
towards avenues for EBP. The key components are as follows; 1) Sources of Evidence, such as clinical practice 
guidelines, research syntheses or local experience, fixed in decision support tools that relay key points in 
response to patient assessment data; 2) Facilitation, through leaders in the field with professional craft 
knowledge within individual and organisational parameters; 3) incorporation of Patient Preferences; and 4) 
Context, patient measurement, real-time feedback about intervention outcomes. The dynamics between these 
components are represented in Figure 1. These factors interplay to dictate the uptake of knowledge and the 
success of nursing interventions in improving patient outcomes. The research described in this thesis utilises the 
OFKTF Framework’s Sources of Evidence component in its examination of evidence-based RB management 
and clinical practice guidelines (CPGs). It was identified as the most appropriate for this research based on its 
grounding in the well-established PARIHS framework and its specific direction towards EBP and development 






Figure 1. Outcomes-Focused Knowledge Translation Framework (Doran and Sidani, 2007) 
 
The research reported in this Masters thesis focuses on the sources of evidence within the OFKTF as a starting 
point to quality care. Sources of Evidence within the framework include research syntheses, clinical practice 
guidelines, or experience and these have been the foundation of the exploration of KT to support non-
pharmacological care of RB within this research. Research hierarchies place CPGs as first line for direct care 
[52] and as such this thesis examined the strengths and weaknesses of CPGs to assist care staff to use non-
pharmacological methods to alleviate Responsive behaviours in people with dementia. Nursing interventions 
work at the point of care to incorporate evidence into practice and to improve quality care. Nursing interventions 
have been found to directly mitigate symptomatic, functional, staff-based and economical outcomes [53]. 
However, the term ‘nursing intervention’  as used within the OFKTF limits such approaches to nursing 
populations. The ratio of nurse to residents’ decreases and thus other carers such as care workers within RACFs 
need to be focus and as such, this thesis will direct its investigation of Sources of Evidence away from nursing 
populations towards care workers. It begins with an examination of the evidence base available for the 
development of guidelines, an evaluation of existing guidelines against an international standard is then reported 
followed by an evaluation of the utility of the most commonly used guidelines. Specifically, this thesis involves 




the quality of currently available CPGs (Study 2) and investigation into expert recommendations of these 




This research aimed to address the question;  
 
In the context of Knowledge Translation, what is the usefulness of different methods to identify best ‘sources of 
evidence’ for care staff on the non-pharmacological alleviation of affective Responsive behaviours in dementia? 
Methods 
A Sequential multiple methods approach was used to explore Sources of Evidence as a basis for KT. 
Specifically, it examined the utility of different methods to provide clear practice recommendations for the non-
pharmacological intervention of affective RB in residential care facilities. The thesis describes three 
complementary studies:  
 
Study 1 - Assessing the utility of panoramic meta-analysis to guide recommendations for the non-
pharmacological intervention of affective symptoms in dementia 
 
Study 1 responded to the vast amount of literature available to care staff and the need to syntheses this to 
promote EBP. Following a systematic search of  available literature for the affective symptoms ‘cluster’ of 
behaviours dementia,  the utility of panoramic meta-analysis to pool estimates across previous systematic 
reviews and meta-analyses and the ability of this synthesis method to identify best sources of evidence for care 
staff in practice were assessed.  
 
Study 2- Identification and Assessment of Quality in Clinical Practice Guidelines for Responsive behaviours 
 
Study 2 uses a systematic literature search to identfy and assess currently available CPGs using the Intervention 




sources of evidence to support care staff in the alleviation of RB.  
 
Study 3 - Expert recommendation of clinical practice guidelines and components that influence 
recommendation 
 
Study 3 responded practically to the findings of Study 1 and 2. It argued that advanced methods of synthesis are 
currently unable to inform EBP and so practice must also rely on expert recommendation as a source of 
evidence to inform care. Study 3 used a survey method to explore the recommendations made by experts 
(Behaviour consultants from the Dementia Behaviour Management Advisory Service (DBMAS)) for CPGs and 






Chapter 2 - Assessing the utility of panoramic meta-analysis to 
guide recommendations for the non-pharmacological intervention 





It is estimated that by 2050 there will be 135 million people living with dementia [54] prompting a critical need 
for improved diagnosis, treatment and management strategies to improve their quality of life [1].  Responsive 
behaviours (RB) affect over 90% of those with dementia [55] and have been identified as a primary burden on 
care staff within Residential Aged Care Facilities (RACFs) [56]. Mismanagement of RB within these facilities, 
such as the use of sedative pharmaceuticals or restraint, leads to poorer resident outcomes for those with 
dementia affecting mortality, morbidity and quality of life [7].  
 
Due to the diverse range of symptoms encompassed within RB, there is a need for the establishment of sub-
groups to reflect particular characteristics of the symptoms and their potential response to management 
strategies [11]. RB (or BPSD as they are commonly referred to in the literature) are most often divided into 
three groups; affective, behavioural and psychotic symptoms [57]–[59]. It is argued that affective symptoms are 
the most burdensome within the healthcare system as they encompass the three most prevalent non-cognitive 
symptoms of dementia; apathy, depression and anxiety [11], [60] as well as aggression and agitation. They are 
thus of primary concern in the pursuit of appropriate responses to RBs and form the focus of this review.  
 
It has been estimated  that 84% of people with dementia living in RACFs are prescribed medication to relieve 
symptoms [28] and medications are often the first choice treatment strategies for nursing staff due to ease of 
administration and rapid effect. This is despite the fact that systematic reviews have found little evidence of the 
effectiveness of pharmacological treatments but have identified increased problems with side effects such as 




medications to alleviate responsive behaviours give rise to the need to review the current literature for non-
pharmacological interventions that will provide EBP alternatives to the use of medications. Given this, it is 
necessary to review the current literature for non-pharmacological alternatives to promote the use of evidence 
based strategies in care.  
 
Meta-analysis – A starting point for informing evidence based intervention 
for RB? 
 
Systematic reviews and meta-analyses aim to collate empirical research evidence and have been dubbed the 
‘platinum standard of evidence’ [61] which sit atop the hierarchy for best evidence [52], [62]. Although 
systematic reviews and meta-analyses sit atop evidence hierarches, they rely on narrow search criteria for 
specificity and thus overarching insights into the scope of research evidence in a research domain cannot be 
gained through a singular systematic review targeting one intervention or one symptom [63]. Systematic reviews 
of systematic reviews offer a solution to synthesising this ever growing literature but fall short of quantifying the 
evidence. A panoramic meta-analysis allows for pooling effect estimates over systematic reviews and meta-
analyses [64] and thus allows comparison of effectiveness for the abundance of interventions available for the 
numerous presenting symptoms to generate clear recommendations. Given the diversity of research on the non-
pharmacological interventions for RB and the numerous reviews and meta-analyses, a panoramic review may be 
an appropriate means for acquiring the best quantitative evidence to direct research and practice. A panoramic 
methodology would be more suitable than alternative synthesis, such as systematic review of CPGs, due to its 
ability to quantify comparisons of specific primary data to hone into specific symptoms or interventions, as 
opposed to more collective clinical recommendations in CPG which reflect review conclusions which cannot be 
segmented for specificity. It is this ability to segment into symptoms that allows for creation of tools like 
the ‘matrix’ (p.26). This type of tool can easily be adapted to identify evidence-based strategies for 
care workers. This type of methodology fits as a source of evidence by creating a more complete 
picture of the evidence as a starting point for EBP and tools. However, this is adopted with 
acknowledgement of limitation of this methodology such as overlap of primary studies, missing data not 
included in reviews and the influence of primary study quality on heterogeneity. As the affective symptoms pose 




review to identify successful interventions by attempting to build a complete intervention by symptom matrix 
for the reduction of affective symptoms. 
 
The specific review question to be addressed by this review is; 
Can panoramic methods identify best sources of evidence to support RACF staff regarding the non-
pharmacological management of affective symptoms in residential aged care facilities? 




The Cochrane Collaboration [66] has recommended that meta-analyses “should not make any attempt to 
combine evidence from randomised trials (RCT) and non-randomised studies (NRS)” (13.2.1.1) as this may 
limit external validity [61]. However, the exclusion of NRS  violates the notion of total evidence which attempts 
to gather all relevant information on a subject and limits the ability to judge a hypothesis as ‘informed’ [61].  
This review aimed for the highest quality evidence level in accordance with the current guidelines and thus 
performed a meta-analysis of RCT studies only.  
 
Thus, well-conducted systematic reviews of RCTs have been be considered as level I research evidence for 
guideline development or other evidence appraisal. Meta-analyses that are not part of a systematic review or that 
refer to a set of RCTs might be considered level I or lower evidence, depending on the context. Systematic 
review and meta-analyses of observational data have been considered at the level of observational data and 
graded within this evidence level by the risk of bias in the analysis (compilation of adjusted or unadjusted 
analysis and other criteria) [61], [66]. 
 
Systematic Search and Study Selection 
 




to October, 2014 using the three phase JBI Methodology for Umbrella Reviews – Search Strategy 
(Section 2.6.5) [67]. Systematic searches of JBISIRI, Scopus, Cochrane, PubMed, Medline, EMBASE, 
DAREPROSPERO, Epistemonikos and CINAHL databases were conducted by one author (CK). Search strings 
included suitable indexing terms (i.e., MeSH terms and keywords) on (1) dementia (e.g., dementia; Alzheimer’s 
disease) and (2) BPSD (e.g., apathy, neuropsychiatric, affective) (see Appendix A for full search strategy).  
 
PICO 
This review adopted the Cochrane Collaboration suggested PICO framework (Participants, Interventions, 
Comparators, Outcomes) [66] in the development of research questions and inclusion criteria.  
Participants 
This review considered all studies that have a focus on those with a diagnosis of dementia living within 
Residential Aged Care Facilities (RACF). These facilities are often called nursing homes or assisted living 
facilities. It also considered studies in which those with dementia form part of a larger population but only when 
it was possible to extract data relating only to those with dementia.  
Intervention 
This review considered all research studies that specifically address non-pharmacological interventions for one 
or more affective symptoms of dementia.  
Comparators 
Included studies used control groups with “no treatment” or “care as usual” for matched participants.  
Outcome 
This review considered resident outcomes in regard to affective symptoms. These were primarily measured by 
the use of the Neuropsychiatric Inventory (NPI), Cohen-Mansfield Agitation Inventory (CMAI) and the Cornell 
Depression Scale (CDS). Articles were included if they were peer-reviewed meta-analyses or systematic 
reviews addressing the management of affective symptoms within residential aged care facilities. Titles and 
abstracts of identified articles were screened to determine inclusion eligibility. Title and abstracts were 
considered eligible for full text analysis if they made reference to one or more RB or non-pharmacological 
intervention. Full text versions of potential references were screened for final selection by one author (CK) to 




identify any additional relevant references. 
 
Data Abstraction and methodological quality assessment  
 
This review aimed to identify and include systematic reviews for the non-pharmacological management of 
affective symptoms which met a minimum standard of quality. To do this, the reviewers adopted the AMSTAR 
tool for reviewing quality of systematic reviews (Appendix B). The AMSTAR is a validated tool with high 
inter-rater agreement, reliability, construct validity, and feasibility that provides a means to assess systematic 
reviews for methodological quality [67]. Assessment of quality of systematic reviews was deemed more 
appropriate than assessment of individual RCTs included within reviews to limit the scope of the study and in 
reflection of high-quality reviews including RCT assessment within their data collection. Quality was adopted 
following the AMSTAR checklist terminology. This was done to remain consistent with included 
references. Two independent reviewers assessed the studies where the author (CK) assessed 100% of studies 
and supervisor (RF) assessed 20% to assess agreement. There was 100% consensus on the quality of studies.  
 
Data were abstracted from systematic reviews and meta-analyses meeting inclusion criteria. Data abstracted 
included intervention type(s), study design, search methods, year published, number of included RCTs, use of 
data extraction methods, quality assessment, and inclusion of a meta-analysis. Primary study reports of 
identified RCT’s for non-pharmacological management of one or more affective symptom were identified from 
these reviews. Intervention type(s), year published, number of participants, before/after treatment means and 
standard deviations for control and experimental conditions and results from meta-analyses were abstracted 
from RCT reports.  
 
Reviews were scanned manually by one author (CK) to identify primary RCT studies covered in two or more 
reviews or analyses. When identified, preference was given to reviews/meta-analyses according the following 
(ordered) criteria; reviews with RCT’s included within multiple analyses; availability of numerical data; 







Statistical analysis  
Data were analysed using RevMan Review Manager 5.3 software and guidelines for meta-analyses obtained 
from the Cochrane Handbook for Systematic Reviews of Interventions [66]. Where Standard Deviations (SD) 
for change scores were not available within primary RCTs, calculations using correlation coefficients were 
performed. When available data did not allow for coefficient calculation, final SDs were used. Analyses 
included tests for effect size (Standardised Mean Difference) via a random effects model. SMD was adopted to 
allow comparison of various measures for the same outcome. A random-effects model was used under the 
assumption of exchangeability, and to account for the variance stemming from studies coming from 
various populations (see Section 10.10.4.4 Implementing random-effects meta-analyses [66]) . Statistical 
heterogeneity was explored using the I-Squared statistic and interpreted using The Cochrane Collaboration’s  
guide to interpretation of I2 [66];  
 0% to 40%: might not be important 
 30% to 60%: may represent moderate heterogeneity 
 50% to 90%: may represent substantial heterogeneity 
 75% to 100%: considerable heterogeneity 
Analyses were arranged by intervention type and outcome measure. For RCT’s reporting measures for global 
RBs or neuropsychiatric symptoms, such as the BEHAVE-AD, results were excluded from analyses.  Evidence 
of publication bias was assessed using funnel plots and Egger’s regression.  
 
Matrix Formation 
This study developed a symptom by intervention comparison matrix in an attempt to generate clearer 
recommendations for care. This matrix adopted a shading system to visually represent levels  of evidence for a 
specific combination. Where a study with a statistically significant result (p<0.05)  had a large enough sample 
size (N>300), had sufficient data to perform systematic review (N>4) and had acceptable heterogeneity 
(I2<75%), it would be considered to have strong evidence. If only two of these conditions are met, a study would 
be considered to have moderate evidence. If only one of these conditions was met, it would be considered to 






Search and study selection 
 
The search identified 2037 potential reviews (Figure 1). After duplicates were removed, 1389 articles remained. 
Of these, 1262 were excluded after title and/or abstract screening revealed studies as non-systematic reviews, 
not in English, not focused on RB or non-pharmacological interventions and being community/home-based 
interventions. 127 full text articles were assessed for eligibility. Of these, following a complete reading of the 
text, a further 75 were excluded for the reasons stated above as well as reviews not including at least one RCT. 




In the interest of including only best evidence, articles meeting eligibility criteria underwent a quality 
assessment using the AMSTAR. A quality cut off point was set at a score of 7 out of 11  based on previous 
research identifying the Australian Government’s National Health and Medical Research Council typically 
supporting interventions that reached 65% of quality assessment [68]. Based on this, a further 23 review articles 
were excluded from the analysis.  
 
Exclusions for Duplicate Primary Studies 
 






Figure 2. Flow diagram of reviews identified by search and those included in the analysis. 
Study Characteristics  
The remaining 20 reviews are detailed in Table 2. Reviews were published between 2005 and 2014 and included 
a median of 4 (IQR 3-5, Mean=4.65) randomised control trials for non-pharmacological interventions for 
affective symptoms. The AMSTAR Score for systematic reviews and meta-analyses included within this review 
had a median of 8 (IQR 7-10, Mean=8.75).  




definition included in clinical practice guidelines or primary studies; 
1) Music Therapy; engage the regular use of sounds, melodies and/or rhythmic movement provided 
through live music, singing or listening to cds or dvds [78] 
2) Light Therapy – Sensory Intervention using varying sources of light to promote synchronization of 
circadian rhythms [79] 
3) Therapeutic Touch; including acupressure and massage to promote relaxation [78] 
4) Aromatherapy- Sensory Intervention using essential oils  [70] 
5) Activities Based Intervention – or Therapeutic recreation - a range of leisure activities that focus on 
improving daily functioning, independence and well-being. Examples include cooking activities, 
gardening or social interventions [78] 
6) Exercise Based Intervention- some form of gentle to medium level physical activity such as walking 
and/or movement which targets balance, mobility, flexibility and/or strength [78] 
7) Environmentally Based Intervention - dementia appropriate modifications to physical environments 
[78] 
8) Multi-Sensory Stimulation (including Snoezelen) – Sensory Intervention through provision of 
unpatterned visual, auditory, olfactory, and tactile stimuli  [80] 
9) Behavioural/cognitive-behavioural interventions - based on behavioural theory (i.e. classical and 
operant conditioning) and/or cognitive theory (i.e. changing dysfunctional thinking) typically involving 
the active participation of carers [78] 
10) Person Centred Care (PCC) and Provision for Unmet needs - specific care protocols or services that are 
implemented within RACFs [78] 
11) Reminiscence Therapy Reminiscence-based interventions involve using life histories and experiences 
to improve well-being. [78] 
12) Psychological Intervention – individual or group psychological treatment focused on enhancing 
adjustment and mood, using cognitive behavioural therapy (CBT), life review and/or on strategies to 
improve memory, using a cognitive rehabilitation approach [81] 
13) Staff Development Intervention - staff training and support programs which target BPSD [78] 
14) Social Intervention including Simulated Presence Therapy (SPT) – recordings of family members, 




Table 2. Characteristics of included Reviews 




Included RCTs Meta-analysis 
Blythe and Chang, 2009 8 3, 8, 9, 10, 14 6 N 
Brodaty and Burns, 2012 7 5, 6, 8, 10, 11, 14  4 N 
Forbes et al., 2013 11 6 4 Y 
Forbes et al., 2014 11 2 4 Y 
Forrester et al., 2014 10 4 4 N 
Fossey et al., 2014 10 10, 13 4 Y 
Gonzalez and Kirkevold, 
2013 
7 7 1 N 
Kong et al., 2009 8 7, 9, 14 5 Y 
Kverno et al., 2009 8 4, 8, 14  5 N 
Livingston et al., 2014 10 1, 8, 9  8 N 
Livingston et al., 2005 7 1, 12  4 N 
Pieper et al., 2013 8 9, 10 3 N 
Reuther et al., 2012 8 13 2 N 
Seitz et al., 2012 7 5, 6 4 N 
Testad et al., 2014 7 5, 6, 11, 12, 13  13 N 
Ueda et al., 2013 8 1 8 Y 
Verkaik et al., 2005 8 8, 9, 12  4 N 
Viggo Hansen et al., 2006 10 3 1 Y 
Watson et al., 2012 11 3, 4, 6  8 N 




Synthesis of Results 
 
Results from meta-analyses are summarised below. Table 3 summarises the results for each non-
pharmacological intervention and reports the number of included studies and observations, effect size with 














I2 Statistically Significant Symptoms 
(observations), # RCT, effect 
size[CI], p-value, I2 (N>1)1 




66%  Anxiety (222), 6, -0.52[-1.03, -
0.01], p=0.05, I2=67% 
Exercise Programs 9 1398  
(695, 703) 
-0.13 [-0.27, 0.01], 
p=0.07*,** 
38%  
Light Therapy 3 553  
(347,206) 
-0.16 [0.53, 0.21], 
p=0.40** 
71%  Apathy (36), 1, -0.99[-1.96,-0.01], 
p=0.05 
Therapeutic Touch 5 263  
(153,109) 
-0.30 [-0.60, 0.00], 
p=0.05** 
27%  
Aromatherapy 4 472  
(241,231) 









97%  Agitation (267), 4, -0.89[-1.48,-
0.30], p=0.003, I2=78% 
 Apathy (160), 3, -5.83[-10.36,-
1.30], p=0.01, I2=99% 
 Anxiety (125), 1, -1.81[-2.23,-
1.39], p<0.0001 




3 260  
(162,98) 





2 72  
(37,35) 





2 134  
(76,58) 
-0.17 [-1.02, 0.68], 
p=0.70** 









1 This column shows the results from meta-analyses combining relevant RCTs. It states the number of RCTs 











91%  Aggression (60), 1, -0.79[-1.31,-
0.27], p=0.003  
 Agitation (645), 4, -0.70 [-
1.41,0.01], p=0.05, I2=94% 
Reminiscence 
Therapy 




0%  Depression (119), 2, -0.51 [-0.87,-
0.14], p=0.004, I2=0% 
Staff Development 
Intervention 
5 1206  
(625,581) 
-0.61 [-1.81, 0.59], 
p=0.32** 
99%  Depression (293), 1, -4.49[-4.92,-
4.06],p<0.00001 
 Aggression (53),1, 
1.13[0.54,1.72], p=0.0002 
Social Intervention 3 184  
(92,92) 
-0.84 [-1.88, 0.20], 
p=0.11 
88%  
* Nearing statistical significance 
** Some participants counted twice due to RCTs reporting for different symptom outcomes within one study sample 
 
 
Analysis of RCTs for non-pharmacological interventions for affective symptoms found statistically significant 
effects (SMD -0.52 [-0.69, -0.35], p<0.00001). However, this result is rendered uncertain  by high 
heterogeneity of included studies (I2=92%) indicating incomparability of included studies. Subgroup analysis of 
intervention types revealed five significant effect sizes; Music (SMD -0.37 [-0.62, -0.13], p=0.003), Therapeutic 
Touch (-0.30 [-0.60, 0.00], p=0.05), Multi-Sensory Stimulation (SMD -2.79 [-3.91, -1.67], p<0.00001), Person 
Centred Care (SMD-0.56 [-0.98, -0.13], p=0.01), and Reminiscence Therapy (SMD -0.50 [-0.84, -0.16], 
p=0.004), and one nearing significance; exercise therapy (-0.13 [-0.27, 0.01], p=0.07). Although these show 
promise, samples were small. Further, it is unlikely that an intervention would act equally for all symptom 
presentations and thus this is likely to contribute to heterogeneity in included studies.  Analysis of outcomes 
found four of five symptoms significantly influenced by non-pharmacological intervention; Depression (SMD -
0.54 [-1.02, -0.05], p=0.03), Agitation (SMD -0.40 [-0.63, -0.18], p=0.0005), Anxiety (-0.51 [-0.93, -0.09], 
p=0.02) and Apathy (-2.15[-3.69, -0.61], p=0.006), with the exception of aggressive symptoms. However, it is 
unlikely that any intervention will equally influence these symptoms as these results could suggest and so it is 
insufficient to recommend non-pharmacological interventions for any sort without further distinction. Lack of 
distinction for interventions within symptom analysis is likely contributing to large heterogeneity due to the 
large diversity of intervention types used for each symptom, unique methodological approaches and varied 




types. This division revealed twelve symptom and intervention combinations reaching statistical significance.  
 
Matrix of Evidence and Recommendations 
 
Specific recommendations on the effectiveness of an intervention can only be made when symptom by 
intervention analysis is performed. To illustrate, although pooled analyses for staff development interventions 
had a significant positive effect, it would be misleading to give a blanket recommendation for them for RB 
interventions as detailed analysis shows that Staff development interventions have positive effects for 
depression but produce negative effects for aggression. Similarly, the pooled analysis suggests that aggressive 
symptoms are not responsive to non-pharmacological approaches yet with intervention specificity it is revealed 
that aggression has statistically significant positive response to Multi-Sensory Stimulation (SMD -4.32 [-4.96, -
3.67], p<0.00001) and Person-Centred Care (SMD -0.79[-1.31, -0.27], p=0.003) and has statistically significant 
negative response to Staff Development Interventions (SMD 1.13 [0.54, 1.72], p=0.0002).   Clarification of 
recommendations can only be achieved when analysis by both outcome and intervention takes place. This 
review, in acknowledgement of this, developed a symptom by intervention comparison matrix in an attempt to 
generate clearer recommendations for care.  
Table 4 presents the level of evidence corresponding to interventions by outcome and summarises 
recommendations to improve evidence level. The shadings indicate the strength of the evidence such that 
interventions with moderate evidence or above could tentatively be recommended within care facilities for the 














Anxiety Agitation  Apathy Aggression 
Music Therapy a, c a a, b, c b b 
Exercise Programs b a, b a, b, c a, b b 
Light Therapy a, b, c a, b a, b, c a, b b 
Therapeutic Touch b b a, b b a, b 
Aromatherapy b b a, b b b 
Multi Sensory Stimulation a, b, c a, b a, b, c a, b, c a, b 
Activities Based Intervention b b a, b, c a, b b 
 
Environmental Intervention b b a, b b a, b 
Behavioural Intervention a, b b b b a, b 
Psychological Intervention a, b a, b, c a, b b b 
Person Centred Care a, b b c b a, b 
Reminiscence Therapy a, b b b b b 
Staff development a, b b b, c b a, b 
Social Intervention b b a, b, c b b 
 
Key 
 Strong evidence 
 Moderate evidence 
 Limited evidence  
 Limited evidence against 
 Moderate Evidence against 
         Strong evidence against 







a. Sample size issues(n<300), Increase sample size 
b. Investigate ability for systematic review, if unable (N<4), perform RCTs 
c. Heterogeneity issues (I2>75%), Investigate heterogeneity 
 
The symptom by intervention matrix revealed only three analyses that provide sufficient evidence for the 
recommendation of management strategies. These are marked as having strong evidence within Table 4. These 
include music therapy for anxiety (-0.52[-1.03, -0.01], p=0.05, I2=67%), staff development for depression (-
4.49[-4.92, -4.06], p<0.00001) and person-centred care for aggression (-0.79[-1.31, -0.27], p=0.003). In this 
review, music therapy included interventions using group music, rhythmic exercise, calming music, preferred 
listening, use of percussion or instruments, active listening and singing.  Staff development focused on the 
training in individualised care, dementia care mapping and psychosocial care and the effect of ongoing peer 
support. Person-centred care included individualised care plans, assessment and management of unmet needs, 
showering and towel-baths and dementia care mapping.  
 
Risk of Bias  
 
A funnel plot was used to investigate publication bias in the studies. The shape of the funnel plot for the global 
comparison indicated no obvious asymmetry (Figure 3). Furthermore, viewing funnel plots for statistically 
significant intervention types revealed no significant asymmetry. The Egger’s regression analysis (p=0.308) 





Figure 3. Publication Bias Funnel Plot 
Discussion  
 
In response to the magnitude of available literature this review utilised a panoramic meta-analysis to identify 
non-pharmacological intervention for the management of affective symptoms of dementia.  
Analyses revealed statistically significant reductions in RB with non-pharmacological interventions providing 
evidence that non-pharmacological interventions can have a positive effect on affective symptoms. Despite this 
positive trend, this result is rendered uncertain by the heterogeneity of included studies. Delving further into 
this reveals various possible sources of heterogeneity. As the Cochrane handbook says “A common analogy is 
that systematic reviews bring together apples and oranges, and that combining these can yield a meaningless 
result. This is true if apples and oranges are of intrinsic interest on their own, but may not be if they are used to 
contribute to a wider question about fruit”. Applying this to our study would suggest that although interventions 
for various symptoms are covered by one umbrella of ‘affective interventions’, this may be too wide to combine 
within one analysis. Given this, the analysis was then divided into its symptom and intervention types. However, 




intervention implementation or study design, participant diversity, and variation in outcome measurement.  
Individual non-pharmacological intervention did not positively influence all affective symptoms or allow for 
clear recommendations and thus further divisions by symptom and intervention within this analysis were 
necessary to draw conclusions. 
 
Further analysis revealed that only three symptom by intervention combinations could be recommended 
including music therapy for anxiety, staff development for depression and person-centred care for aggression. 
On the basis of this panoramic analysis these represent the best options currently available for sources of 
evidence to support care practices. However, significant limitations to these analyses were evident in sample 
size, heterogeneity and number of included RCTs. Until the recommendations matrix reflects higher evidence 
levels, implementation of these interventions should be undertaken cautiously. Given this, it is premature to 
present these sources of evidence as definitive.  It is more accurate to regard them as a general indication of best 
available evidence based on a limited literature. The panoramic method in this instance falls short of providing 
definitive recommendations but does give general insight into some positive interventions.  
 
Limitations and direction 
 
The panoramic method did not produce clear recommendations.  This may be due to limitations such as no 
interventions having the sample size required to make generalizable conclusions and heterogeneity of outcome 
measures. Within pharmacology, a medication would not be recommended for widespread use without multi 
stage clinical testing with sample sizes of several thousand [100]. This review has a total of 8,361 observations 
across 14 distinct intervention types (mean 597.2 observations per intervention). There is some strong evidence 
for the effect of non-pharmacological interventions but not enough to create definitive conclusions. This review 
found support for three interventions within the matrix. However, all three had sample sizes less than 300 
included in the analyses and two of the three had only one included RCT in its analysis. Although there is 
promise in these three symptom intervention combinations, caution must be applied when recommending these 
as a source of evidence in EBP. More research into all intervention types, as well as high quality systematic 
reviews and meta-analyses are needed to reach the level of rigour found in high quality medical research and to 





This review focused on the group of affective symptoms as the literature shows them to be the most burdensome 
for the health and aged care systems.  There would be merit in investigating other categories, however, this was 
beyond the scope of the current research. Although the researcher attempted to identify all eligible articles 
within the systematic search, researching using wider or different search parameters could identify articles 
which were overlooked. Similarly, assessing systematic reviews and meta-analyses using a different quality 
assessment could alter articles identified as ‘acceptable’ quality. Future systematic reviews and meta-analyses 
should look towards the AMSTAR and other quality assessments in the preparation of their reviews to avoid 
elimination from panoramic reviews.  Fourteen intervention types were identified within the literature. Although 
a broad list, this does not necessarily represent the totality of available intervention types for affective 
symptoms. The inclusion of wider search parameters within included reviews could allow for a more 
comprehensive menu of interventions to assess the utility of the panoramic method. Heterogeneity was the 
largest limitation within this review. Heterogeneity across analyses was considerable suggesting they may 
include articles that are too diverse to compare. Future research is required to investigate sources of 
heterogeneity and should be designed in accordance with Cochrane guides to eliminate future syntheses facing 
similar phenomenon.  
 
Although it is premature to identify best sources of evidence for care of affective RB, this panoramic review and 
resulting matrix do enable clear recommendations for research. No one intervention type was tested for all 
affective symptoms, or any symptom held against all interventions and thus there is a large gap within this 
research. It is impossible to conclude any intervention is best for a symptom without complete literature for each 
intervention for each symptom and thus future research should aim to address recommendations within the 
matrix. Researchers should aim to bring all symptom intervention combinations to an adequate standard by 
addressing the three main recommendations which are presented within the matrix structure; 1) to increase 
sample size if there are sample issues (n<300); 2) to perform systematic reviews if there is adequate literature 
(N>4) or conduct RCTs to build literature; and 3) to investigate issues of heterogeneity if analyses had high 
heterogeneity (I2>75%). By addressing these recommendations within the matrix structure, the ability for 
panoramic methods to provide best evidence will be strengthened.  
 
In line with current guidelines and evidence hierarchies, this review included only RCT studies. However, RCTs 




dementia due to varying levels of cognitive decline and behavioural disruption [101] making the study 
population difficult to engage in intervention studies involving controlled research design. Furthermore, 
environmental factors such as facility policy, staff non-compliance issues and turnover rates limit the number of 
RCTs conducted for RB and reduce the plausibility of RCTs as a means for best evidence [101]. In parallel, only 
RCTs included within previous synthesis reviews were included in the analyses and many primary studies may 
have been missed. Search strategies that included primary studies, could have neutralised this limitation but was 
not done in the current study to limit included studies to manageable scope.  
 
Questioning the “holy grail” in research with people with dementia 
 
In accordance with meta-analysis guidelines set out by The Cochrane Collaboration [66] and in the interest of 
external validity, this review did not include non-randomised studies (NRS). However, exclusion of NRS does 
violate the notion of total evidence and limits the ability to judge a hypothesis as ‘informed’ [61].This is 
particularly relevant in this review given the difficulty performing RCTs in the target population making NRS  
often more appropriate than studies involving controlled research design [102].  The reality is that the 
homogeneity necessary for successful RCT experimentation may be unobtainable when exploring social or 
psychological phenomenon in diverse human populations - with RB a prime example [102].  These challenges 
occur within the biomedical model and the dominance of medical research to explain all disease in biological 
terms, ignoring the impact of psychological and social factors of any condition [102]. The biomedical model has 
long been claimed to be an example of objective science using quantitative methods such as the RCT and the 
only valid perspective for understanding disease and illness [103]. Deductive methods result in a narrowness of 
scope [104]; that is, misrepresentation of the complexities intrinsic to the humanity attached to human 
populations. Without the respect of these complexities we are in danger of robbing those with dementia of their 
humanity and relegate them to the status of objects of study [105].  Inclusion of NRS or a mixed-method 
approach is likely to be necessary to identify the best sources of evidence for interventions for RBs in the people 
with dementia under consideration in this study. 
 
Although RCTs have high internal validity, when properly implemented they put constraints on population 
eligibility and thus reduce external validity [104]. This restriction often eliminates those from culturally or 




results are not generalizable to the majority of those with dementia who have at least one of these or other co-
variates.  Furthermore, measurement tools for RB have not been developed or evaluated for diverse populations 
[106] and thus results using non-validated tools cannot be considered accurate for diverse groups. These 
methods decrease generalisability through sampling criteria whilst simultaneously increasing social inequity 
through the inclusion of only those who match the majority; usually those from English-speaking backgrounds, 
without disability, and are high functioning or in the earlier phases of the disease.  
 
The matter of external validity in dementia research poses the question; why are RCTs and meta –analyses of 
RCTs held as the ‘platinum’ evidence base for studying RB and other dementia-related conditions? The answer 
lies in distribution of funding. This issue has been dubbed “The Elephant in the Room” for dementia research 
[107], an issue directing research decisions which is often overlooked. Today, grant funding bodies focus on 
determining the efficacy of intervention which privilege research with quantitative methods such as RCTs [108]. 
As a result, research into the qualitative nature of diseases such as psychological and social determinants are 
underfunded and viewed as ‘soft-sciences’.  Biomedical models ignore social and psychological phenomenon 
[102], yet the methodologies from this are illogically adopted when studying the social and psychological 
implications in dementia. The quantitative bias at work in funding bodies dictates that qualitative research grant 
applications are judged using quantitative criteria leading to perceptions that the research is ‘soft’ or less 
generalizable than quantitative counterparts [109]. This leaves qualitative researchers with no option but to 
adopt mixed-methods approaches that appear viable for external grants [109] often at the cost of meaningful 
exploration. Additionally, synthesis of mixed methods research further complicates issues with severe statistical 
issues when trying to combine unmatched non-randomised trials resulting in low internal validity [66]. 
 
The RCTs that dominate medical fields may be unable to deal with the complexities of working with people 
with dementia with all of their associated complexities, suggesting the need for a new method for synthesis that 
allows for individual difference, social theories and diversity without sacrificing rigor. Best practice hierarchies 
suggest that when systematic reviews and RCTs fail to support evidence based decisions, care staff should adopt 
the next level in the best practice, ‘evidence based clinical practice guidelines’ [52]. Research into the 
knowledge translation within health fields suggests that when synthesis such as meta-analyses are unable to 
produce clear care recommendations, then attention must move towards other forms of sources of evidence 









This study aimed to discover if panoramic syntheses can identify best sources of evidence to support the non-
pharmacological intervention of the affective symptoms of RBs. However, this study was unable to do so owing 
to large heterogeneity and sampling issues within included RCTs. Although the panoramic methodology was 
unable to produce best evidence in this review, it did reveal positive associations for the non-pharmacological 
interventions for affective symptoms and was able to generate three tentative recommendations for evidence 
based care practices. The method revealed various interventions that are promising for the reduction of RB but 
the evaluations do not yet have sufficient statistical power to allow confident clinical recommendation of best 
evidence due to limitations such as small sample sizes and heterogeneity.  
 
It becomes evident that gold standards from the reductionist biomedical model that dominate medical fields may 
have failed to grasp the complexities when working with people with dementia and attached complexities 
suggesting the need for a new method for synthesis that allows for individual difference, social theories and 
diversity without sacrificing rigor. Best practice hierarchies suggest that when systematic reviews and RCTs fail 
to support evidence based decisions, care staff should move towards the next level in the best practice, ‘evidence 
based CPGs based on systematic reviews of RCTs’ [52]. However, recent syntheses of CPG have not been 
adequate to support consensus [111]. While research would benefit from exploring methods of synthesis beyond 
meta-analysis of RCTs, care staff require assistance to evaluate the next best level in the best practice hierarchy, 
CPGs [52].  This evaluation will need to replace quantification of effect sizes with such considerations as 
relevance, quality, useability and resident outcomes. Beyond research syntheses, KT research nominates 






Chapter 3 – Identification and Assessment of Quality in Clinical 




For those seeking non-pharmacological approaches, Clinical Practice Guidelines (CPGs) can support clinical 
decision making to guide the appropriate intervention for RB [111]. CPGs are “ evidence based statements that 
include recommendations intended to optimise patient care and assist health care practitioners to make decisions 
about appropriate health care for specific clinical circumstances” [36]. CPGs are often developed by 
multidisciplinary expert panels to present evidence-based care recommendations to healthcare practitioners and 
care staff. Best practice hierarchies suggest that when synthesis methodologies, such as panoramic reviews, are 
unable to identify best sources of evidence to direct EBP then ‘evidence based clinical practice guidelines 
(CPGs) based on systematic reviews of Randomised Control Trials (RCTs)’ constitute the next level in best 
practice [52].  
 
However, current guidelines may be unhelpful due to a lack of consistency in their recommendations and 
generally weak or low quality evidence informing their development [111]. Clinicians seeking support for the 
non-pharmacological care of RB are often overwhelmed by choice of CPG and have little guidance available to 
determine which available CPGs are of an acceptable quality. Available CPGs must be critically appraised for 
methodological quality to ensure that guidance is based on credible evidence [112]. The ability of CPGs to 
facilitate clinical decision-making and improve care is proportional to their quality, so that if developed on low-
quality evidence they may perpetuate inaccurate treatment advice and poor practice [113]. Given this context, it 
is logical to explore clinical guidelines as a source of evidence to determine which are readily accessible and 
then to evaluate their quality so that clinicians will be better placed to select the guideline(s) most likely to be of 







Systematic Search  
 
A search of the literature was performed to identify CPGs for comparison with the iCAHE Guideline Quality 
Checklist Scores to determine if available guidelines are based on evidence that is of an ‘acceptable’ level.  
A systematic search for existing CPGs for the management of RBs (or BPSD) was performed in Scopus, 
Cochrane, PubMed, Medline, EMBASE, CINAHL databases in July, 2015. This followed the JBI Reviewer’s 
Manual three phase search strategy outlined in Section 2.6.5- Search Strategy [114]. Search strings included 
suitable indexing terms (i.e., MeSH terms and keywords) on (1) dementia (e.g., dementia; Alzheimer’s disease), 
(2) Clinical Practice Guidelines and (3) BPSD (e.g., apathy, neuropsychiatric, affective) (see Appendix B for 
full search strategy).  
The following keywords were used;  
Dementia OR Alzheimer* 
AND 
Guid* OR clinical OR Manag*OR practice OR consensus 
AND 
neuropsychiatric OR BPSD OR behav* OR psycholog* OR non-cognitive OR affect* OR anxi*OR agitat* OR 
depress* OR aggress* OR apath* OR irritab* OR mood  
 
Search limits included articles published in English between 2005 and July, 2015.  Grey literature was searched 
in July, 2015. This included search of organisations that have produced clinical guidelines such as national 
Alzheimer’s Associations, Dementia Behaviour Management Advisory Service (DBMAS) and the National 
Health and Medical Research Council (NHMRC) Clinical Practice Guidelines Portal.  Further, Google and 








Guideline selection and inclusion criteria 
PICOS 
This study adopted the Cochrane Collaboration suggested PICOS framework (Participants, Interventions, 
Comparators, Outcomes, Study Design) [66] in the development of its inclusion criteria.  
Participants 
This study considered studies focusing on participants with a dementia diagnosis living within Residential Aged 
Care Facilities (RACF). Studies that included participants with dementia as part of a broader population were 
considered only if it was possible to extract data relating only to those with dementia. 
Intervention 
Interventions addressing the non-pharmacological management of one or more affective symptom within studies 
were considered relevant in this review.  
Comparators 
Control groups with “no treatment” or “care as usual” for matched participants were considered.  
 
Outcome 
Responsive behaviours were the primary outcome measure. Articles including guidelines which referenced one 
or more responsive behaviour were deemed relevant.  
Study 
Articles were included if they addressed one or more clinical practice guideline for non-pharmacological 
management of responsive behaviours. 
 Titles and abstracts of retrieved citations were screened by one author (CK) using the broad criterion that the 
article included description of the management of one or more responsive behaviour for those with a dementia 
diagnosis living within RACFs. If considered relevant, full-text guidelines were retrieved. Full text articles were 








This research utilised the Intervention Centre for Allied Health Evidence (iCAHE) Guideline Quality Checklist 
to test the quality of evidence within guidelines. While the AGREE II Instrument is a research focused quality 
assessment for CPGs and is the most commonly used within the current literature [115], the iCAHE is 
considered to have some advantages in this research. It has been tested against the AGREE II for Content and 
construct validity, inter-tester reliability and clinical utility [116]. Further it was found correlating for Scope & 
Purpose, Stakeholder involvement, Underlying evidence / Rigour, and Clarity with the AGREE II [116]. The 
iCAHE has advantage in this instance over the AGREE II due to its clinical focus and the need to disseminate 
quality evidence within clinical settings. It is therefore most appropriate for KT strategies which aim to promote 
EBP. Furthermore, the iCAHE was found to be easier to use, take less time, and it can be used by a single 
assessor with no prior training [116]. The iCAHE uses criteria such as included search criteria, availability as 
full-text, review process and useability in its evaluation of CPG quality. Although more appropriate in this 
instance, the iCAHE has disadvantage in its management of conflict of interest assessment. It has lower 
correlation with the AGREE-II Domain 6 – Editorial Independence [117] which identifies if ‘Competing 
interests of guideline development group members have been recorded and addressed’. However, given its high 
correlation with AGREE-II Scores, it is the most appropriate clinician-focused rapid assessment tools.   
 
Data Abstraction and Quality criteria 
 
A form was developed to extract the following CPG characteristics; title, publication date, organization, 
country, developed methods, number of references, topics covered and the 14 items of the iCAHE Quality 
Checklist (Appendix A). The iCAHE assessment of guidelines was conducted by one researcher (CK). A quality 
cut-off standard was set at 65% (9/14 possible score) within iCAHE assessments. This cut off was chosen in 
response to the Australian NHMRC typically approving CPGs that reach a quality score above 65% on AGREE 
assessments and the high correlation between these two assessment tools [68]. Guidelines were considered 







Coding of Recommendations 
High quality guidelines were manually scanned and coded by one author to identify and compare 
recommendations for care. This was categorised by symptom and associated recommendations (if 
any). See Table 7.  
Results 
A total of seven guidelines for the non-pharmacological care of RB were identified via systematic search and 
subject to quality assessment using the iCAHE checklist. Three guidelines were sourced from Australia, with 
others coming from British Columbia, United Kingdom and international associations. The majority of 






Table 5. Identified Clinical Practice Guidelines, details and iCAHE Score 
 




The NICE-SCIE Guideline on Supporting People 
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2 Behaviour Management: A Guide to good Practice 
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Behavioural and Psychological Symptoms of 
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5 Best Practice Guideline for Accommodating and 
Managing Behavioural and Psychological Symptoms 
of Dementia in Residential Care: A Person-Centered 
Interdisciplinary Approach 
2012 British Columbia 8 
6 Reducing Behaviours of Concern (ReBOC) 2012 DBMAS, Australia 7 
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Management of the behavioral and Psychological 










Table 6. iCAHE Assessment of Identified Clinical Practice Guidelines 
 
Of the seven guidelines identified, three were found to have an acceptable iCAHE score based on a 65% 
acceptability score (9/14 possible score); Behaviour Management: A Guide to good Practice (DBMAS), NICE-
SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care and 
Assessment and Management of People with Behavioural and Psychological Symptoms of Dementia (BPSD) A 
Handbook for NSW Health Clinicians.  Two guidelines, Behaviour Management: A Guide to good Practice 
(DBMAS) and NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and 
Social Care (NICE-SCIE), were considered of ‘high’ quality based on iCAHE scoring greater than 65% (>9/14 
possible score).  
Question/Guideline 1 2 3 4 5 6 7  
Is the guide readily available in full-text? x x x X x X X 100% 
Full reference list provided? X X x X X X X 100% 
Summary of recommendations provided? X X  X X   57% 
Completion date available X x X X X X X 100% 
Anticipated review date?        0% 
Provides date of when literature was 
provided? 
X X X     
43% 
Strategy for finding literature clear? X X X     43% 
Hierarchy to rank evidence? X       14% 
Appraisal of evidence X X      28% 
Link between hierarchy and appraisal to 
recommendations 
X X      
28% 
Developers clearly stated X X X X X X X 100% 
Does developers qualification link to 
purpose of guide and end-users 
X X x X X X X 
100% 
Purpose and target users clearly stated X X x X X x x 100% 
Readable and easy to navigate X x x X X X  86% 




The majority of guidelines scored for questions regarding availability (100%), references (100%), completion 
date (100%), developer details/purpose (100%), purpose/target audience (100%) and usability (86%).  The 
majority of guidelines did not score for questions regarding summary of recommendations (57%), review dates 
(0%), details of literature search (date, strategy 43%), hierarchy of evidence (14%), appraisal of evidence (28%) 
and the link between hierarchy and appraisal (28%).  
 
The Behaviour Management: A Guide to good Practice (DBMAS) is a 190-page guide which separated Modules 
according to symptom types. It uses the term BPSD to refer to the variety of RB interventions. It uses a person-
centred approach with specific considerations when working with CALD and Indigenous populations. The 
NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, in 
comparison, consisted of 392 pages with only one dedicated section regarding non-pharmacological 
interventions for RB. It uses the term non-cognitive symptoms or “behaviours that challenge”. There is no 
symptom categorisation which made navigation of the evidence more difficult.  
 
In regard to care recommendations for general RB, aggression and nocturnal disruption, there was overlapping 
conclusions between the two high-quality guidelines. Both recommended person-centred approaches for general 
RB with the NICE-SCIE specifying the A-B- C (antecedents-behaviour-consequences) model, individualised 
interventions for aggression and sleep hygiene interventions for nocturnal disruptions. For general RB, the 
NICE-SCIE gave evidence for aromatherapy and staff training as well as person-centred approaches. The 
DBMAS guide gave some support for light massage, individual behavioural therapy, bright light therapy and 
Montessori activities in addition to the mutual recommendation of individual interventions. There was some 
overlap in individualised and person-centred approaches between the two guides, but also large discrepancy for 
sensory approaches. For Agitation, the DBMAS recommends music as best evidence where the NICE-SCIE 
recommends Aromatherapy and some support for doll therapy. There was some overlap for depression as the 
NICE-SCIE recommends group-based CBT, where DBMAS recommends behavioural approaches plus exercise 
programs. While both recommended hygiene interventions for nocturnal disruption, the NICE-SCIE also 
recommends daily walking and increased light exposure.  
 
No specific evidence or recommendations were given by the NICE-SCIE for Anxiety, Apathy, Disinhibited 





The DBMAS guide divided evidence into symptom modules for ease of navigation, had a more complete 
approach to symptoms, and allows for clear conclusion regarding CALD and indigenous groups and has the 
benefit of symptom specific modules. However, the hierarchy of CPGs using the iCAHE quality assessment 
identified the NICE-SCIE as higher than the DBMAS.  Although the hierarchy was able to identify which 
guidelines were of high quality it did not support the CPG with the clearest care recommendations and is thus 





Table 7. Comparison of High Quality CPGs 
 DBMAS NICE-SCIE 
General RB Person-centred approaches focusing on 
underlying causes* 
A-B-C model*, Aromatherapy, 
staff training  
Aggression Individualised psychosocial interventions*, 
some support for light massage, individual 
behavioural therapy*, bright light therapy and 
Montessori activities 
individualised Behavioural 
intervention involving carers * 
Agitation Music therapies Aromatherapy, some evidence 
for doll therapy 
Anxiety Multicomponent interventions which target 
environmental, biological and psychosocial 
factors contributing to anxiety. Some 
evidence for music, Montessori, and 
psychotherapies. 
NA 
Apathy Therapeutic recreation using “question-asking 
reading”, small group, individual/tailored, 
Montessori based and kit-based activities. 
NA 
Depression Exercise and behavioural approaches* CBT Groups* 




Nocturnal Disruption The NITE-AD intervention using sleep 
hygiene education* 
Sleep hygiene education*, daily 
walking and increased light 
exposure  
Psychotic Symptoms GentleCare Program NA 
Vocally Disruptive 
Behaviour 
Therapeutic recreation, limited for sensory 
(aroma, music, touch) and outdoor activities. 
NA 
Wandering Environmental interventions, sensory 
interventions and touch therapies categories. 





CPGs are often a first-line approach to support clinicians in the non-pharmacological care of RB. However, 
there are multiple CPGs available and little guidance available to identify which available guidelines are of an 
acceptable quality. In response, this study aimed to investigate if evidence appraisal was helpful method for 
identifying CPGs as a source of evidence which support clear recommendations for practice. First, it identified 
which clinical guidelines were available for the non-pharmacological care of RB and then it used the iCAHE 





There was great variation between the seven identified guidelines based on iCAHE quality assessment scores, 
methods of development and their quality, comprehensibility and clinical recommendations.  Three of seven 
guidelines were of an acceptable level based on the 65% acceptance level and only two of these were 
considered to be ‘high’ quality (>65%); Behaviour Management: A Guide to good Practice (DBMAS) and 
NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care.  
Variation between these high quality guidelines and other assessed guideline were largely seen in regard to 
inclusion of recommendation summary which allows for ease of use, search strategy including dates which give 
indication of being ‘up to date’ and the inclusion and link between a hierarchy and appraisal of evidence 
indicating quality of included evidence. This variation in quality gives further evidence of the perplexing choice 
for care staff when faced with RB and the need to clarify CPG choice to promote EBP. 
 
There was some correlation between the recommendations of the two identified high-quality guidelines, but also 
large differences and gaps in recommendations, which made it difficult to identify best evidence. The DBMAS 
guide had a more complete schedule of symptom recommendations and divided evidence into symptom 
modules for ease of navigation.  However, variation between the two high quality CPGs raised concerns 
regarding ability of this method of identify best sources of evidence to inform care staff. The appraisal of CPGs 
ranked the NICE-SCIE higher than the DBMAS despite the advantages seen in the latter in regard to care 
recommendations for more symptoms and specificity of recommendations. It became evident that, although the 
iCAHE assessment was able to identify high-quality CPGs, it did not support the CPG which allowed for 
clearest care recommendations.  This may reflect the issue that quality assessments may not reflect the 
practicalities of guideline use within Australia. Guideline selection may not be as simple as ranking quality and 
selection of the highest. Investigations into clinical expertise regarding how clinicians select and recommend 
guidelines was a logical progression in this investigation.  
 
Guidelines with lower scores could improve quality assessment scores by addressing common pitfalls. For time 
short staff providing care for those with a dementia diagnosis, quickly being able to access care 
recommendations is invaluable yet the majority of guidelines failed to include a summary of recommendation. 
This adaption is paramount to enable translation of research evidence into practice. No identified guideline 




effort to remain up to date for researchers. It is suspected that review dates may be attached to affiliate websites 
rather than in guidelines themselves. Quality of included evidence was a primary area where guidelines lacked. 
In this, the majority failed to provide dates of when included literature was provided and the search strategies for 
finding literature. It is important to ensure evidence is up to date and thus guidelines should endeavour to rectify 
this neglect. A hierarchy to rank evidence allows care staff to determine front line treatments and subsequent 
treatments based on reliable evidence. Similarly, the evidence within guidelines and these hierarchies must be 
subject to appraisal to give indication of evidence strength behind care recommendations. Unfortunately, 
hierarchy and appraisal of evidence were very underrepresented in the identified guidelines. Improving these 
areas would facilitate the application of quick and efficient care strategies based on high quality evidence.  
Limitations 
This research used a systematic search to identify CPGs. Although the researchers tried to identify all eligible 
guidelines, researching using wider or different search parameters could identify guidelines overlooked. 
Similarly, assessing guidelines using a different quality assessment could alter guidelines identified as 
‘acceptable’ quality. This is particularly so in regards to identification of Conflicts of Interest.  
Conclusion 
An abundance of research literature has led to a perplexing state for care staff when selecting CPGs as a source 
of evidence for the non-pharmacological care of RB. This study aimed to first discover which guidelines were 
accessible and then to rank these according to quality standard to clarify choice for care. Of seven identified 
CPGs, three were of an acceptable level and two were considered ‘high quality’; Behaviour Management: A 
Guide to good Practice (DBMAS) and NICE-SCIE Guideline on Supporting People with Dementia and Their 
Carers in Health and Social Care.  Although the DBMAS guide allowed for clearer recommendations, was more 
complete and divided evidence into symptom modules for ease of navigation, it was ranked below the NICE-
SCIE. This may be due to the assessment of CPGs not reflecting the practicalities of CPG use within practice. 
Although assessment and rank of CPG quality was a viable means to identify high quality guidelines, it was 
insufficient in isolation to determine best sources of evidence to support care staff regarding the non-
pharmacological alleviation of RB. Further investigation into clinical expertise regarding the selection and 





Chapter 4 - Components that influence expert recommendation 
and the Quality of Evidence included in recommended guidelines 
– a focus on affective symptoms in dementia. 
 
Background 
For  those  seeking  non-pharmacological  approaches,  clinical  practice  guidelines  (CPGs)  can  support  
clinical  decision  making  to  guide  the  non-pharmacological management  of  the  RB   [111].  Care staff 
within RACFs require ongoing  support  and  the  provision  of  easy -to-use  research  tools such as CPGs to 
improve EBP [35].   Despite a number of CPGs being available, there is little guidance in the selection of 
appropriate guidelines to facilitate the use of evidence in practice [11]. In time constrained RACFs, it is difficult 
for care staff to allocate time and focus from resident care to investigate EBP and thus accessible and user-
friendly sources of evidence consolidating EBP is needed [13]. To date, systematic review and meta-analyses 
have been unable to identify best sources of evidence to support practice when caring for responsive behaviours 
(RB). Best practice hierarchies suggest that when these methodologies are unable to generate clear evidence to 
support practice decisions, ‘evidence based clinical practice guidelines (CPGs) based on systematic reviews of 
RCTs’ constitute the next level of evidence to be used in support of EBP. 
However, choice of CPGs is complicated by a number of factors. These include 
 the lack of consistency among guidelines recommendations  
 generally weak or low-quality evidence informing guideline development [111] 
 low correlation between the results of quality assessment and clear recommendations or the usability of 
CPGs to support care in practice   
 
In line with this, a review of dementia care guidelines in Europe found inconsistency in methodological quality 
and inclusion of recommendations for psychosocial interventions [118] for RB in people with dementia. A 
systematic review of recent dementia CPG including the alleviation of RB [111] found no clear messages by 




Mixed messages were found for most interventions and none were included in a sufficient number of 
guidelines to generate clear recommendations. Research into the effective transfer of knowledge into practice 
decisions suggests that when synthesis of the literature is inadequate to support evidence-based care decisions, 
then focus must be shifted towards other sources of evidence including expert opinion [51], [110]. Given this 
complex picture of the strengths and weaknesses of guidelines, this research surveyed experts regarding their 
use of CPGs in actual practice and identify those characteristics of the guidelines that are associated with a 
recommendation of use.   
 
Further, caution must be applied when comparing generalised CPG recommendations with symptom sub-groups 
that have distinctive incidence, trajectories over time, biological correlates, psychosocial determinants and 
unique responses to management strategies [11]. It is thus likely that recommendation of guidelines in reference 
to specified sub-syndrome would vary to that of a blanket RB recommendation. The affective cluster has been 
described as the most burdensome within the healthcare system as it encompasses the three most prevalent non-
cognitive symptoms within dementia; apathy, depression and anxiety [11], [60] as well as aggression and 
agitation [15], [57].   
 
This study aimed to determine if expert opinion on CPGs is an appropriate method for synthesising research to 
identify best sources of evidence regarding non-pharmacological RB alleviation. In this, it identified the CPGs 
that are currently being recommended by experts to care workers’ for the alleviation of RB in residential 
facilities, included care strategies, the components of a CPG that contribute to their recommendation, 
alternatives care support systems and comparison with recommendation made for affective-only symptoms.  As 
the importance of methodological quality and evidence-base cannot be overlooked [116] this research aimed to 
consolidate expert recommendations with quality assessment of CPGs to determine if expert recommendations 








A descriptive cross-sectional survey design was adopted to explore experts’ recommendation of CPGs at the 
time of survey.  The aims of the survey were to understand factors influencing expert recommendations of 
CPGs, professional preference of CPG, features which contribute to their recommendation, recommendation 
with a focus on affective symptoms and any additional support systems they recommend to assist care workers 




Guidelines were selected using the Systematic Search, inclusion criteria PICOS and  
Data Abstraction and Quality criteria outlined in Chapter 3.   
 
Survey Instrument Development 
 
A web-based survey was developed using Qualtrics software by one author (CK) to explore expert 
recommendation of CPGs for the non-pharmacological management of affective symptoms of dementia within 
residential facilities. Prior to distribution, the survey was piloted using think-aloud processes to ensure that the 
survey questions were clear, understandable and capable of collecting appropriate information. The think-aloud 
technique was used with a convenience sample of five  DBMAS consultants via phone interviews to ensure face 
validity [119], [120]. All phone conversations were audio-recorded. Participants were asked to read and answer 
each survey item while explaining their thought processes out-loud. For each survey item, participants were 
asked about the clarity of wording, ease of understanding, technical issues, appropriateness of answer choices 
and had opportunity for any further comments. Based on the results, survey items were altered and survey 
format adjusted.  
 
The final survey contained seven question regarding CPGs for the alleviation of RB. The term BPSD was used 
over responsive behaviours in this survey due to its prevalence and commonplace within the literature and 
available CPGs which are familiar to participants.  
 




Other (please specify)), state of employment and professional background (academic, aged care provider, 
nursing, medicine, psychology, social work, occupational therapy, other).  
 
The final version of the survey was designed for completion via the web using Qualtrics software. The survey 
was made available in a web-browser and smart phone-app format. 
 
Table 8. Survey Questions 
In the past 6 months, have you recommended any 
clinical practice guidelines to direct care staff (e.g. 
nurses or attendants who provide direct care of 
residents) to support their non-pharmacological 
management of BPSD in the residential setting? 
Yes 
No (Please explain your reasons) 
In the past 6 months, which of these guidelines have 
you recommended to direct care staff (e.g. nurses or 
attendants who provide direct care of residents) to 
support their non-pharmacological management of 
BPSD in the residential setting? 
List of identified Guidelines. 
Yes  
No 
Unfamiliar with guide 
If asked to recommend clinical practice guidelines, 
which would you select as your first three 
recommendations to support direct care staff within a 
residential setting in their non-pharmacological 
management of BPSD? Please indicate the order of 
your recommendations. * 







How would you rate the importance of the features 
listed below in contributing to your 
recommendations of clinical practice guidelines to 
direct care staff in residential care facilities for the 
non-pharmacological management of BPSD?  * 
Ease of access (e.g. online pdf download) 
Ease of use 
Quality of included Evidence (e.g. based on 
systematic review of RCTs or experiential opinions) 
Source (e.g. Department of Health or a university 
group) 
Format (e.g. iphone app or hard copy booklet) 
Complexity of language (medical terms or a simple 
description) 
Content (e.g. identifies appropriate intervention for 
symptoms, instruction for applying interventions)  
Other (please specify) 
 
Scale: Not at all Important – Extremely Important 
 
*Repeated with reference to affective symptoms only.  
 
Recruitment and sampling 
 
The survey was distributed via email to 54 participants working as behaviour consultants within the Dementia 
Behaviour Management Advisory Service (DBMAS), Australia. DBMAS is an Australian Government funded 
organisation charged with the responsibility of providing care and advice to those with dementia and their 
professional and personal carers [121].While the DBMAS is now a single national organisation at the time of 
the survey the DBMAS services were provided by state based organisations. The DBMAS consultants were 
identified as experts in RB intervention as they are a front-line response for management of symptoms of 
dementia and represent diverse multi-disciplinary advisory teams.   
 
Participants were sent a brief description of the study via email and a website link which directed them to the 
Participant Information Sheet, Consent Form and survey questions. The survey was available in a web-browser 




DBMAS team managers on two occasions. Ethics approval was obtained via the Human Research Ethics 
Committee at the University of Wollongong:  consent to participate was indicated via an online checkbox prior 




The survey data were coded and analysed using Qualtrics software and SPSS v.21. Pearson correlations were 




A total of 27 experts, 77% female, completed the survey (response rate of 50%). The median age bracket of 
respondents was 46-55 (M=48.6, SD=1.14: range 18-25 to Over 55). Participants were predominately from 
nursing background (62%) followed by occupational therapy (15%), psychology (12%) and education (12%).  
Consultant location was distributed across six states; 
 Victoria 32% 
 Western Australia 20%  
 Queensland 16%  
 New South Wales 12% 
 Northern Territory 12% 
 South Australia 4% 
 Australian Capital Territory 4% 
 
Recommendation of Guidelines 
 
Figure 4 displays participant indication of recommendation and familiarity with each CPG.  The highest-rated 
guideline for alleviation of RB was the Behaviour Management: A Guide to Good Practice. Of the 96% who 




previous six-month period. This was followed by Reducing Behaviours of Concern (ReBOC) guideline with 
88% and the Assessment and Management of People with Behavioural and Psychological Symptoms of 
Dementia (BPSD) A Handbook for NSW Health Clinicians with 28% of participants having recommended these 
guidelines respectively within the previous 6 months.  
 
Figure 4. Rates of Guidelines Recommendation and Familiarity
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Recommendation Yes 4 25 22 7 3 2 2 
 




12 0 0 6 8 9 10 
RB First  0 16 7 0 0 1 0 
 
Second 1 7 10 3 0 1 2 
 
Third 1 1 5 8 5 2 2 
 
First  1 13 6 2 0 1 0 
Affective RB Second 1 5 11 2 0 1 3  






Table 10. Features of Importance Data 
  







Very Important Extremely 
Important 
RB Ease of access  0 0 0 14 10  
Ease of use 0 0 0 10 14  
Quality of 
included Evidence  
0 0 4 14 6 
 
Source  0 0 6 15 3  
Format  0 0 6 13 5  
Complexity of 
language   
0 1 3 10 10 
 
Content  0 0 1 11 12 
Affective RB Ease of access  0 1 0 14 11  
Ease of use 1 0 1 9 15  
Quality of 
included Evidence  
0 2 3 14 7 
 
Source  1 2 6 15 2  
Format 0 1 8 11 6  
Complexity of 
language  
1 1 5 9 10 
 





Table 9 presents results for participant indication of recommendation and familiarity, as well as an indication of 
preference when recommending each CPG for RB and affective symptoms. There was a significant correlation 
(r=0.935, p=0.000) between responding expert preferred CPGs for RB and those preferred for affective 
symptoms. There was no statistically significant difference between preference answers for RB and affective 
symptoms (t (22)=1.279, p=2.15).   
 
 
Figure 5. Preference of Clinical Practice Guidelines 
 
A Pearson’s r correlation analysis revealed a statistically significant relationship between the rate of familiarity 
and rate of recommendations (r=0.942, p=0.002).  There was a significant correlation (r=0.919, p=0.003) 
between guidelines experts had recommended and their indication of first preference. As shown in Figure 5, the 
highest preference of guideline was the Behaviour Management: A Guide to Good Practice (24 indications, 16 
as first preference) followed by Reducing Behaviours of Concern (ReBOC) guidelines (22 indications, 10 as 
second preference) and the Assessment and Management of People with Behavioural and Psychological 
Symptoms of Dementia (BPSD) A Handbook for NSW Health Clinicians (11 indications, 8 as third preference).  
 
 
For questions regarding guidelines recommended by experts within the previous six months prior to survey, 
respondents were given the option to answer Other (Please Specify). Although no other CPGs were identified, 
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several answers gave insight into alternative formats of resources recommended to assist care staff respond 
appropriately to RB. The most noted responses included the online DBMAS and AAV Help Sheets (2 
indications), the TRACS Quick Reference Cards (3 indications) and the NPS website for medication (2 
indications).   
 
Features of Importance within a Guideline 
 
Table 10 displays data for indication of importance for features contributing to recommendations. Results are 
shown for RB and affective RB. There was a significant correlation (r=0.982, p=0.000) between features 
contributing to recommending general guidelines for alleviating RB and guidelines specifically for RB 
involving affective symptoms. There was no statistically significant difference between answers regarding 
features for RB and affective symptoms (t(22)=-4.007, p=.007).  
 A One-Way ANOVA found the ranking of features to be significant (F(13)=12.935, p=0.02) suggesting a 
significant variation in how the features contribute to guideline recommendation. The effect size for this 
variation was large (ETA2 =.917). Ease of use was ranked as the most important consideration when 
recommending a CPG for RB. This was followed by content, ease of access, complexity of language, quality of 
included evidence, format and finally source.  
 
When questioned about features which contribute to recommendations, participants had the option of “Other 
(Please Specify)”. One participant stated “Online is great but many residential care staff do not have access to 
computers and if they do printing large book/guideline is difficult. Hardcopies are still requested a lot. Use of 
Smart Phones and ipads is growing but many facilities in my experience do not have access to tablets/ipads”. 
Another participant stated, “No cost and comprehensible in a short period of time are most important”.  
 
 
Recommendation and Quality 
 
Correlation of expert recommendations with the iCAHE scores found a non-significant low correlation (r=0.21, 




assessments. This is evident in Figure 6 which compares iCAHE Score of individual guidelines with their rate 
of recommendation.  
 
 





To clarify best sources of evidence, this study aimed to investigate expert recommended guidelines, to 
determine if recommended guidelines are of a suitable quality for practice for the non-pharmacological 
symptoms of dementia in residential care settings, to identify features of importance when recommending 
guidelines and if there are variations in recommendation for symptom sub-groups.  
 
 
Primarily, this research aimed to discover which CPGs experts have recommended and the reasoning behind this 
recommendation. There was a clear preference for the recommendation of Behaviour Management: A Guide to 
Good Practice which was recommended at least once, and rated within the top three preferred guidelines, by the 
























this may be the result of it being developed by the DBMAS who also employed all participants. It is likely that 
participants were trained to use this guide, encouraged to recommend this guide or even involved in its 
development. This may have biased the participants. Further, the workplace culture within the DBMAS could 
affect the uptake of alternative CPGs. Standard practice and the culture of usual practice within an organisation 
has been found to either be reinforcing EBP or inhibiting it [122]. Given this, it is likely that DBMAS standard 
policies influence consultant CPG recommendation behaviours and contribute to the high recommendation of 
the DBMAS guideline.  However, despite issues regarding the influence of workplace culture and potential bias 
this CPG remains a high quality guideline with expert preference and should be recommended above others for 
care workers seeking guidance.  
 
This research compared expert recommendations with quality assessment of CPGs to determine if expert 
recommendations are correlated with ‘acceptable’ level of evidence quality as deemed by the iCAHE 
assessment. Of the seven guidelines identified, only two could be said to be of a ‘high’ level; Behaviour 
Management: A Guide to good Practice (DBMAS) and the NICE-SCIE Guideline on Supporting People with 
Dementia and Their Carers in Health and Social Care. Over all the guides identified, there was no significant 
correlation between expert recommendations and the iCAHE scores suggesting discrepancy between this 
assessment and experts’ recommendations.  
 
The most recommended guide was the DBMAS guide which was also rated as high quality by its iCAHE score. 
While its popularity may in part be due to its familiarity to the participants the effect of its quality cannot be 
ruled out.  In this vein, familiarity was found to be significantly correlated with likelihood to recommend 
another guideline, the ReBOC guide, which was rated second for recommendation despite lower iCAHE score 
as it is also developed by the DBMAS. There was a significant drop from 88% to 28% for the next most popular 
guideline giving further evidence that familiarity was the key factor influencing guideline recommendation. 
Ensuring familiarity may be key to the introduction and dissemination of high quality CPGs. Future research 
and practice should aim towards development and introduction of high quality guidelines to ensure end-users are 
being familiarised with the highest quality guides to improve care practices.  
 
Another primary aim of this research was the identification of the key features of a guideline which make it a 




recommending a CPG. Usability is defined as when a “user is able to do what he or she wants to do the way he 
or she expects to be able to do it, without hindrance, hesitation or question”  [123]. Usability is especially 
critical in the design, dissemination and implementation of information such as CPGs [123]. Usability has been 
described as testing ‘Quality in Use’ with a focus on functionality, reliability, efficiency, maintainability and 
portability [124]. This finding may be instructive to guideline developers and researchers as it points to the 
possibility that the next step is not to develop more high quality guidelines, but to increase the usability of 
existing guides. In this respect, assessing the ‘quality’ of guidelines could identify those with high quality 
content as candidates for reform using usability research to improve practical application within real world care 
procedures. In this same light, ‘Content (e.g. identifies appropriate intervention for symptoms, instruction for 
applying interventions)’ was ranked second. These highest ranked features hint towards usability and 
application. Similarly, ‘Complexity (medical terms or a simple description)’ was ranked above ‘Quality (e.g. 
based on systematic review of RCTs or experiential opinions)’ suggesting that a guideline is more useful when it 
is written in language understandable by users rather than using medical jargon and that this is even more 
important to users than the quality of the evidence. When questioned about features which contribute to 
recommending a particular CPG, one participant added a comment regarding access to computers. Although 
format was ranked 6th, there is the important issue raise here that format dictates accessibility. Although there is 
a growing focus on digital formats they limit access by staff and thus lower familiarity, which has a higher 
correlation with recommendation. Perhaps, given the limited access to technologies in many care settings, hard 
copy guidelines are still the most useful despite issues of being ‘chunky’ and hard to navigate quickly.  Another 
participant raised issues regarding cost and comprehension. Two important ideas are raised; one, that funding 
many influence access and so cheaper guidelines will be more sort after; and two, that comprehension (both 
Ease of Use and complexity) need to be prioritised. Guideline developers need to explore options that maximise 
easy access and usability with end-users.  
 
There was also a very high, statistically significant, correlation between reporting for RB versus affective 
symptoms. It was hypothesised that recommendation of guidelines would differ when directed towards affective 
symptoms, however, this was not supported by this research. Participant responding for preference of guideline 
and features of importance when recommending a guideline had no significant variation for generalised RB to 
affective-only symptoms. Results suggest that experts did not vary their recommendations based on symptom 




reflects unique incidences, trajectories, biological correlates, and psychosocial determinants [11], high quality 
CPGs tended to address individual symptoms rather than cluster groups. It is likely that experts, in line with 
CPGs, recommend based on RB symptom presentations individually rather than on symptom groups. However, 
these conclusions are limited by sampling size and scope.  
 
Limitations and Recommendations  
 
Although this research reached a 50% response rate of all eligible DBMAS Consultants within Australia, the 
total number of participants is small. Given this, the power of the calculations is limited and the results should 
be treated with caution. There was an uneven gender distribution within the sample with large majority of 
participants being female. Although this is reflective of the female dominated professional backgrounds 
identified (e.g. nursing, psychology), larger samples would be necessary to eliminate any bias.  All participants 
were from one government funded programme. This organisation was deemed to represent an expert panel by 
the researchers but does not necessarily represent the totality of experts within this research topic. Further, this 
organisation also developed the highest ranked CPG and thus it may be that participants had familiarity bias 
towards this guideline due to continued exposure, encouragement to use internal CPGs or involvement in CPG 
development. It may also be common and accepted practice to use this guideline and thus increases its 
recommendation rates.   Exploration of alternate sources of expert opinions and CPGs would be advantageous 
for a more comprehensive exploration. This broader approach could include not only other governmental 
departments within health and policy but also with care staff within residential care facilities, their managers and 
with residents directly.  Future research working directly with care staff populations would be advantageous in 
the pursuit of EBP. Repetition of the research with wider recruitment avenues would increase statistical power 




Although results from this study have not been definitive, it does provide guidance towards best sources of 
evidence for practice. The Behaviour Management: A Guide to good Practice (DBMAS) is a high quality 
guideline with expert preference and should be tentatively recommended above others as a starting point for 





With regard to the development of new guidelines, several important topics have been raised.  
 Guidelines should aim to include the features ranked as most important by experts (ease of use, 
appropriate language, content and ease of access primarily) while adhering to the quality standards 
defined by the relevant bodies and evaluations 
  Familiarity was significantly related to likelihood of recommendation and thus quality guidelines 
should aim to increase guideline familiarity through dissemination of high quality CPGs in practice 
 Lack of access to technologies, such as iPads and laptops, due to funding issues within facilities 
suggests that low-cost hard copy format may still be most appropriate 
  Experts were not found to vary recommendations based on symptom subgroups. This is likely a 
reflection of clinical recommendations being individually altered based on presenting symptom, rather 
than broader clusters 
 
The Behaviour Management: A Guide to good Practice (DBMAS) can be recommended as a high-quality CPG 
with expert preference, however, this is done with recognition of limitations in sample, influence of workplace 
culture and bias.  Comparison of quality assessments of CPGs with expert recommendations have enabled the 
identification of the current best source of evidence to support care staff in the non-pharmacological alleviation 




Chapter 5 –Reflection on the findings and Conclusion 
“While trying to be scientific we can often lose sight of the real object of investigation – 
the person.”  
Me, 2018 
With the growing ageing population, and associated age-related disease, the translation of dementia research has 
been called a ‘Global Health Priority’ [1].The support of staff within residential care facilities through 
successful translation of evidence based resources allows for quality in practice and the preservation of dignity 
in care. However, in the absence of clear guidance towards EBP, up to  84%  of  people  with  dementia  living  
in  RACFs  are  prescribed  medication  to  relieve  RB due  to  ease  of  administration  and  rapid  effect [25]–
[28].  The  level  of  care  needed  within  RACFs  is  increasingly complex,  yet the  ratio  of  registered  nurses  
to  less  qualified  care staff   is diminishing for  cost-saving  reasons  [32].  The delivery of EBP can be 
enhanced through  ongoing  support  and  the  provision  of  easy -to-use  research  tools such as Clinical 
Practice Guidelines (CPGs) [35].  Although there is an array of guidelines available to support staff to care for 
RB, to date there has been  a large gap in the literature regarding identification of best evidence,  guidance 
available in choice of guideline and which guidelines facilitate the use of evidence in practice [125]. Knowledge 
translation (KT) works from the premise that research is of little value without real world application and aims 
to increase practitioner tendencies’ to identify and utilise quality research evidence in their practice[39].   
 
This thesis aimed to answer the following research question; 
In the context of Knowledge Translation, what is the usefulness of different methods to identify best ‘sources of 
evidence’ for care staff on the non-pharmacological alleviation of affective Responsive behaviours in dementia?  
 
In response, this research adopted the Outcome-Focused Knowledge Translation Framework (OFKTF) [51] in 
its KT strategy and aimed to clarify best sources of evidence for the non-pharmacological alleviation of RB in 
residential care. Specifically, this was achieved through research syntheses, quality and usability appraisal of 
CPGs and expert opinion as a starting point to evidence-based practice and clarification of care choices. It 




manage RB symptoms using non-pharmacological approaches. An affective symptom focus was taken in order 
to limit the scope of the research to manageable proportions and to focus on the most burdensome symptom 
subgroup [11].  
 
A panoramic meta-analysis aimed to synthesise the available literature on affective symptoms of dementia and 
the non-pharmacological interventions. However, the study was unable to generate clear recommendations for 
the non-pharmacological intervention of affective symptoms. This was owing to large heterogeneity and 
sampling issues within included RCTs or insufficient RCTs to generate power within the calculations. Despite 
this, this review was able to generate three tentative recommendations indicating the best available interventions 
for practice; music therapy for anxiety, staff development for depression and person-centred care for aggression. 
Although other interventions had promise for reducing affective symptoms they did not have adequate statistical 
power for recommendation in practice. Although panoramic methods were unable to identify best sources of 
evidence within this research, they do hold potential for fields where there is a more complete data set or where 
heterogeneity is more controllable.   
 
Beyond the “platinum standard” in research with people with dementia 
 
Study 1, in accordance with the ‘platinum standard of evidence’ [61] and primary sources of evidence within the 
OFKTF [51], included only RCTs in its analysis. However, there are methodological barriers unique to 
dementia research, such as an inability to control variables, medications, lack of resources or inadequate 
consideration of the complexity of social and psychological covariates associated with RB [101], [102], [126], 
[127]. These may negate RCTs and meta-analyses within this field as insufficient. Biomedical models in 
research have led to narrowness of scope [104] where sub-types of dementia are viewed separately and the 
complexities of the condition are overlooked [126]. This is despite the fact that the majority of dementias have 
varying degrees of pathologies [128],  accompanying co-morbidity, polypharmacy, individual difference, 
disease trajectories, measurement of outcomes and cultural and linguistic considerations [126]. The reality is 
that the homogeneity necessary for successful RCT experimentation may be unobtainable when exploring social 
or psychological phenomenon and fall short in obtaining external validity – that is, these conclusions can be 
transferred beyond treatment conditions to clinically applicable external contexts.  Further, funding stigmas of 




that appear viable or ‘scientific’ for external grants [109] often at the cost of meaningful exploration.  
 
Moving away from quantitative rigidity and in light of Study 1 results, best practice hierarchies suggested that 
when systematic reviews were unable to identify best evidence then ‘evidence based CPGs based on systematic 
reviews of RCTs’ [52] are the next level in best practice. In concurrence, the OFKTF identified clinical practice 
guidelines and expert opinion[51], [110] as alternative sources of evidence to support clinical decisions for care 
staff which guided this research beyond Study 1.  
 
There is an overwhelming amount of evidence to navigate when selecting CPGs for the non-pharmacological 
care of RB and there is a  gap in the current literature regarding guidance towards effective CPGs to clarify best 
evidence [125]. To address this, Study 2 appraised CPG quality and usability as a source of evidence. It firstly 
identified which guidelines were available and then assessed quality using the Intervention Centre for Allied 
Health Evidence (iCAHE) Guideline Quality Checklist. Two of the identified CPGs reached ‘high’ quality; 
Behaviour Management: A Guide to good Practice (DBMAS) and the NICE-SCIE Guideline on Supporting 
People with Dementia and Their Carers in Health and Social Care.  Although the NICE-SCIE was ranked first 
for quality, it did not represent best evidence due to limitations regarding extensiveness of included symptoms 
and interventions and usability. The NICE-SCIE scored highest on quality of evidence but the DBMAS guideline 
scored higher on usability. Despite being ranked below the NICE-SCIE for total iCAHE score, the DBMAS 
guide [78] had a more complete schedule of symptom recommendations and divided evidence into symptom 
modules for ease of navigation. Usability should be prioritised when assessing CPG quality and deserves more 
attention in assessment procedures to identify best evidence for KT. Further, this guide is available in hard copy, 
smartphone application and digital formats to suit all clinician preferences and access [129]. It was designed 
based on a combination of systematic review, expert consultation and quality assessments and has 
considerations such as symptom management with CALD and LGBTI populations [129]. Given these factors, 
the DBMAS guide may represent the best source of evidence currently available to promote uptake in care and 
an appropriate starting point for dissemination strategies.  
 
The assessment of CPG quality using the iCAHE checklist was useful to highlight that the quality of guidelines 
in this study were limited by search strategies, dissemination of interventions and including a summary of 




versions and in the development of new guidelines. This method was able to identify two high quality CPGs, 
however, its ranking of quality did not support the identification of best evidence as the DBMAS guide, which is 
more complete in its dissemination of RB interventions and is more usable by care staff, was ranked below the 
NICE-SCIE. Although it is necessary to assess the methodological quality of guidelines to ensure credibility 
[112], critical appraisal of CPG quality as a source of evidence within the OFKTF in isolation is unlikely to be 
sufficient to direct guideline selection, especially in regards to CPG usability. The OFKTF suggested that a 
logical progression in this research was to assess expert opinion to compare how clinicians recommendations of 
guidelines varies from quality assessments [51], [110] and to investigate how experts weigh factors of quality 
and usability when recommending CPGs for alleviation of RB in RACFs. In a search for best sources of 
evidence for the non-pharmacological care of RB, study 3 surveyed a panel of experts on their use and 
recommendation of CPGs. Results were able to give indication towards factors important to experts in guideline 
selection.  Despite limitations regarding familiarity bias, the Behaviour Management: A Guide to good Practice 
(DBMAS) was found to be a high-quality guideline with expert preference and could be the best starting point 
for care staff searching CPGs in their care of RB. This survey gave indication that ease of use, appropriate 
language, content and ease of access should be focus when developing new CPGs. This should be done in 
conjunction with quality assessments and in hard copy format. Within the literature, the tendency is to promote 
digital formats that “provide electronic decision support prompts at the point of choice” (p.117, [130]) due to 
their ability to communicate rapidly, provide feedback and encourage greater adherence to EBP [130], [131]. 
However, access to the internet and digital devices is limited in most RACFs and negate the appropriateness for 
digital copies to promote EBP.  Lack of familiarity has been found to hinder the adoption of resources within 
healthcare [132] and thus future KT endeavours would benefit from focus on increasing care staff familiarity 
with quality evidence to promote EBP.  
 
Contrary to expectations, recommendations did not alter for affective symptoms. It was thought that each 
subgroup would vary due to individual difference, symptom trajectories, biological correlates, and psychosocial 
determinants [11]. However, this was not found within the current research.  Analysis of survey data allowed 
comparison of quality assessment with expert opinion to reveal one high-quality CPG with expert 
recommendation as the best currently available source of evidence for RB intervention.  Both organisational 
bias and workplace practices [122] were likely influencers of the preference for the DBMAS guide in this study 




DBMAS guide may represent the current best source of evidence and may be a logical starting point for 
dissemination strategies to direct care staff towards EBP. In this, it was the combination of the three methods 
that was most useful able to identify best source of evidence to support care staff in the non-pharmacological 
alleviation of RB in dementia.  
 
Despite a large amount of available literature and guidelines addressing RB, to date there has been a large void 
in guidance available to direct care staff care decision and assessment of which methods promote EBP [125]. 
Studies 1 and 2 within this research concluded that the methods utilised were only able to generate tentative 
recommendations for RB intervention. Study 3, although limited by itself, was able to use findings from study 2 
in combination with survey methods to identify one high-quality CPG for RB intervention. Despite limitations 
in all phases of this research, when viewed over all three studies there is quite a lot of evidence generated in the 
exploration of synthesis methods to identify best sources of evidence. This research found the following; 
 Three statistically significant symptom by intervention combinations; music therapy for anxiety, staff 
development for depression and person-centred care for aggression 
 Three CPGs deemed acceptable quality 
 Two CPGs deemed high quality 
 One guideline of high quality with expert preference; Behaviour Management: A Guide to good 
Practice (DBMAS) 
 
Further, it was able to give clear directions towards future research endeavours.  
 Increase power of calculations by additional RCTs and meta-analyses 
 Improve the quality of current and future CPGs 
 Review and development of CPGs should focus on ease of use, appropriate language, content and ease 
of access in conjunction with quality assessments in hard copy format. 









Table 11. Comparison of DBMAS guideline with Panoramic Review 
 DBMAS Panoramic Methods 
Aggression Individualised psychosocial 
interventions*, some support for 
light massage, individual 
behavioural therapy*, bright light 




Multi Sensory Stimulation  
Agitation Music therapies* Multi Sensory stimulation 
(including Snoezelen)* 
 
Anxiety Multicomponent interventions 
which target environmental, 
biological and psychosocial factors 
contributing to anxiety. Some 




Multi Sensory Stimulation 
(including Snoezelen) 
 
Apathy Therapeutic recreation using 
“question-asking reading”, small 
group, individual/tailored, 
Montessori based and kit-based 
activities. 
Multi Sensory stimulation 
(including Snoezelen) 
Light Therapy 





   
*Overlapping conclusions 
 
Table 11 allows a comparison of the Panoramic review from Study 1 with the care options within the CPG 
identified as best in Study 2 and 3. There has been some key cross over in findings. Aggressive symptoms have 




sensory based interventions were supported for agitation and anxiety with stronger evidence for Music Therapy 
specifically. Behavioural interventions for depression were supported across studies. These overlapping 
interventions may be key in determining where the best evidence lies and where to focus attention to clarify care 
choices for RB.  
 
Perhaps each method, although insufficient in isolation, contributes to the larger picture. The outcomes from 
these studies beg the question; can any one method of enquiry such as meta-analyses or survey be held as the 
‘platinum’ evidence base for studying complex topics such as RB and other dementia-related conditions? Study 
1 followed a purely quantitative approach which debated the RCT as the gold standard in research. Although 
this method holds promise for research topics with more complete literature, in the case of RB it was limited. 
The heterogeneity within social and psychological phenomenon such as when investigating populations with 
dementia may render the RCT unable to reach internal or external validity needed in these demographics. These 
investigations are often narrowed in scope by excluding comorbidities, CALD populations or those in advanced 
stages of the disease to appear ‘scientific’ and homogeneous often at the cost of meaningful exploration.  This 
exclusion can diminish the dignity of those with dementia to the status of object of study and the disregard the 
personal, psychological and social facets unique to diseases such as dementia.  The identified guidelines from 
Study 2 mimicked this RCT gold standard debate. They focused more on source and incorporation of RCTs than 
on real world usability. This is despite the fact that experts deemed usability as the most critical component for 
guideline recommendations. Further, a purely quantitative rank system of quality assessments did not identify 
best sources of evidence. A step away from the quantitative standards in Study 3 led to the identification of 
Behaviour Management: A Guide to good Practice (DBMAS) as an expert recommended CPG. Referring back 
to quality assessments in Study 2 revealed that this guide, although ranked second, is the best available option to 
clarify RB care options for care staff. Further comparison of this guideline with results from quantitative 
panoramic methods allows for specific recommendations for research and practice. This mixed approach gives 
weight to the notion that the research into psychological and social determinant are critical when studying 
human phenomenon [109]. Quantitative research, which gives the appearance of being ‘scientific’ and is more 
appealing to funding bodies, is at the forefront of research into social behaviours and psychological 
phenomenon in dementia, yet this is not logical [102]. This is not to say, however, that quantitative research is 
not required but rather that often incorporation of qualitative methods, or mixed methods, are required when 




validation through real world intervention to have meaning [102]. In the case of guidelines, this testing would 
logically be through the examination of usability and resident outcomes. Usability is a theme that continually 
presented itself throughout this research. It is essential within Knowledge Translation research as there is little 




In time constrained RACFs, care staff require guidance towards quality sources of evidence that facilitate 
Evidence Based Practice (EBP) in the alleviation of RB.  This thesis followed the OFKTF to identify sources of 
evidence for non-pharmacological management of RBs through a sequential mixed methods study investigating 
quantitative research syntheses, Clinical Practice Guidelines (CPGs) and expert opinion as a starting point to 
EBP. Quantitative panoramic analyses were unable to identify best evidence due to large heterogeneity and 
sampling issues within included RCTs or insufficient RCTs to generate power within the calculations. Given 
this, alternative methods exploring expert opinion, quality and useability of CPGs were needed to determine best 
evidence for the generation of care recommendations. Quality assessment and survey of experts on 
recommendation of CPGs identified the Behaviour Management: A Guide to good Practice (DBMAS) guide as a 
high quality guideline with expert preference and could be the best starting point for care staff using CPGs in 
their care of RB. Recommendations did not alter for affective symptoms.  
 
Definitively clear recommendations were not found by any one method within this research but rather through a 
cumulative effect of mixed methods.  With regards to the RQ, the studies undertaken were useful to highlight 
that different methods (research synthesis, analysis of guideline quality and expert preference), while 
insufficient in isolation, were useful together to identify best ‘sources of evidence’ for non-pharmacological 
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Appendix A - Search Strategy 
 
Step 1: Preliminary search. 

















Step 2: Extract additional keywords. 
Titles, abstracts, keywords and indexes from relevant articles within the preliminary search were examined. Any 
additional keywords found were added for the focal search.  
 
Step 3: Systematic search 
Systematic searches of JBI, Scopus, Cochrane, PubMed, Medline, PROSPERO, Epistemonikos and CINAHL 
databases will be conducted. Database specific search fields will be applied within each search. Additionally, 
reference lists for included reviews will be examined manually.  
The search for unpublished studies will include, but not be limited to the following; 
 Dissertation abstracts 
 Australian Government and initiatives websites  
 Research institutes in the area; eg. The Dementia Behaviour Management Advisory Scheme (DBMAS) 











 Psychological (Psycholog*) 




 Anxiety (anxi*) 
 Agitation (agitat* 
 Aggression (Agress*) 
 Apathy (apath*) 
 Irritability 
 Mood 
 Dysphoria (Dysphor*) 
 
Dementia OR Alzheimer* 
AND 
Systematic review OR meta-analysis 
AND 
neuropsychiatric OR BPSD OR behav* OR psycholog* OR non-cognitive OR affect* OR anxi*OR 




MeSH: dementia, Alzheimer Disease, systematic review, meta-analysis, psychology, psychological tests, 






Appendix B - Search Strategy for Guideline Selection 
 
Step 1: Preliminary search. 




















Step 2: Extract additional keywords. 
Titles, abstracts, keywords and indexes from relevant articles within the preliminary search were examined. Any 
additional keywords found were added for the focal search.  
 
Step 3: Systematic search 
Systematic searches of Scopus, Cochrane, PubMed, Medline, EMBASE, CINAHL databases will be conducted. 
Database specific search fields will be applied within each search. Additionally, reference lists for included 
reviews will be examined manually.  
The search for unpublished studies will include, but not be limited to the following; 
 Dissertation abstracts 
 Australian Government and initiatives websites  
 Research institutes in the area; eg. The Dementia Behaviour Management Advisory Scheme (DBMAS) 
and Alzheimer’s Australia and the National Health and Medical Research Council (NHMRC) Clinical 
Practice Guidelines Portal.   
 Google and Google Scholar search engines were searched using the search terms ‘dementia’ and 










Dementia OR Alzheimer* 
AND 
Guid* OR clinical OR Manag*OR practice OR consensus 
AND 
neuropsychiatric OR BPSD OR behav* OR psycholog* OR non-cognitive OR affect* OR anxi*OR agitat* OR 
depress* OR aggress* OR apath* OR irritab* OR mood  
MeSH: dementia, Alzheimer Disease, practice guideline, psychology, affective symptoms, anxiety, aggression, 































Appendix D- JBI Data Extraction Form for Review for 
Systematic Reviews and Research Syntheses 
 
JBI Data Extraction Form for Review for 
Systematic Reviews and Research Syntheses 
 







Description of Interventions/ 
phenomena of interest 
 
Search Details  
Sources searched  
Range (years) of included studies  
Number of studies included /  
Types of studies included  




Appraisal instruments used  
Appraisal rating  
Analysis  
Method of analysis  









Appendix E - The Intervention Centre for Allied Health Evidence 








Appendix F -  PRISMA 2009 Checklist 
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